[
  {
    "symptom": "pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.152,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 98,
      "frequency": 0.3035019455252918,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive evaluations of a larger sample of hEDS patients are lacking. The objective of this study was to describe cerebrovascular, autonomic, and neuropathic features of hEDS. This retrospective case-control study was conducted at Brigham and Women's Faulkner Hospital between 2016-2023. Data from hEDS patients who completed autonomic testing and skin biopsies were analyzed. Outcome measures include validated surveys (Survey of Autonomic Functions, Neuropathy Total Symptom Score-6 (SAS)) and autonomic function testing (Valsalva maneuver, deep breathing, head-up tilt and sudomotor), cerebrovascular (cerebral blood flow velocity (CBFv) in the middle cerebral artery), respiratory (capnography), and neuropathic (skin biopsies for assessment of small fiber neuropathy) testing and inflammatory/ autoimmune markers. Total 270 hEDS patients were analyzed and compared to 29 healthy controls. Common hEDS complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastrointestinal, and pain. Orthostatic cerebral blood flow velocity was reduced in 79% of hEDS and correlated with orthostatic dizziness. The head-up tilt test revealed postural tachycardia syndrome (prevalence 33%), hypocapnic cerebral hypoperfusion (22%), orthostatic cerebral hypoperfusion syndrome (18%), and neurogenic orthostatic hypotension (9%). Widespread but mild autonomic failure was present in 90% of hEDS patients on autonomic testing. Small fiber neuropathy using structural criteria was detected in 64%, and using combined structural and functional criteria in 82%. This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread but mild autonomic failure in hEDS.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2025",
          "journal": "American journal of medicine open",
          "doi": "10.1016/j.ajmo.2025.100111",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40843452/"
        },
        {
          "pmid": "33856167",
          "title": "Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders are the most common symptomatic joint hypermobility conditions seen in clinical practice. The 2017 International Classification of the Ehlers-Danlos syndromes replaced previous terms for symptomatic joint hypermobility with hypermobile EDS and introduced the term hypermobility spectrum disorders for patients not meeting diagnostic criteria for hypermobile EDS. Both are diagnosed by applying the 2017 diagnostic criteria, which also excludes other less common conditions presenting with joint hypermobility such as other forms of EDS and heritable connective tissue disorders. Hypermobile EDS is inherited in an autosomal dominant pattern, but it does not have a known genetic mutation to help with diagnosis. Clinical features of hypermobile EDS include joint hypermobility, skin findings, and joint pains or recurrent dislocations. Hypermobile EDS and, less commonly, hypermobility spectrum disorders may also be associated with several extra-articular symptoms, including anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction. The central goals of therapy are managing symptoms, preventing joint injury, and educating patients about their condition. Based on limited evidence, patients with hypermobile EDS/hypermobility spectrum disorders may benefit from physical and occupational therapy, psychological support, and self-management. Primary care physicians play a key role not only in initial recognition, diagnosis, and patient education, but by virtue of their ongoing relationship they can also help oversee and coordinate the multidisciplinary team many of these patients require.",
          "authors": [
            "Kenneth S Yew",
            "Kara A Kamps-Schmitt",
            "Robyn Borge"
          ],
          "year": "2021",
          "journal": "American family physician",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/33856167/"
        },
        {
          "pmid": "34145717",
          "title": "Physical therapy treatment of hypermobile Ehlers-Danlos syndrome: A systematic review.",
          "abstract": "Physiotherapy techniques are regularly prescribed in the hypermobile type Ehlers-Danlos syndrome (hEDS) and they are appreciated by the patients. The objective of this systematic review was to investigate the effect of the different physiotherapy techniques related to the children and adult patients with hEDS. PubMed, SPORTDiscus, Cochrane Library, PEDro, Scopus, and Embase databases were analyzed from inception to April 2020. Characteristics of the studies (authors), patients (sample size, sex, age, Beighton score), and nonpharmacological treatment (length of the program, number of session, duration of the session, and type of intervention), and the results with the dropout rate were extracted. From the 1045 retrieved references, 6 randomized controlled trial with a sample size ranging from 20 to 57 patients were included in the systematic review. There was a huge heterogeneity in the interventions. The durations of the program were from 4 to 8‚Äâweeks. Pain or proprioception demonstrated significant improvements in the intervention group regardless of the type of intervention. A benefit of the inspiratory muscle training was observed on functional exercise capacity. The quality of life was systematically improved. Physiotherapy benefits on proprioception and pain in patients with hEDS even if robust randomized control studies are missing.",
          "authors": [
            "Gregory Reychler",
            "Maya-Mafalda De Backer",
            "Elise Piraux"
          ],
          "year": "2021",
          "journal": "American journal of medical genetics. Part A",
          "doi": "10.1002/ajmg.a.62393",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34145717/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "hy controls. common heds complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastroint"
            },
            {
              "percentage": 79.0,
              "context": "tatic cerebral blood flow velocity was reduced in 79% of heds and correlated with orthostatic dizziness. th"
            },
            {
              "percentage": 90.0,
              "context": "espread but mild autonomic failure was present in 90% of heds patients on autonomic testing. small fiber ne"
            }
          ]
        },
        {
          "pmid": "35750466",
          "title": "Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.",
          "prevalence_mentions": [
            {
              "percentage": 69.0,
              "context": "e of many gut symptoms, including abdominal pain (69% vs 27%, p¬†<¬†0.0001), postprandial fullness (34% vs"
            },
            {
              "percentage": 27.0,
              "context": "ny gut symptoms, including abdominal pain (69% vs 27%, p¬†<¬†0.0001), postprandial fullness (34% vs 16%,"
            },
            {
              "percentage": 9.0,
              "context": "ion (73% vs 16%, p¬†<¬†0.001), and diarrhea (47% vs 9%, p¬†<¬†0.001) are significantly higher in hsd/heds"
            }
          ]
        },
        {
          "pmid": "28186390",
          "title": "Pain management in the Ehlers-Danlos syndromes.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "and may be severe. according to one study, nearly 90% of patients report some form of chronic pain. pain, which is"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "fatigue",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.072,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 39,
      "frequency": 0.12062256809338522,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 8,
      "papers": [
        {
          "pmid": "34454716",
          "title": "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.",
          "abstract": "Despite myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affecting millions of people worldwide, many clinicians lack the knowledge to appropriately diagnose or manage ME/CFS. Unfortunately, clinical guidance has been scarce, obsolete, or potentially harmful. Consequently, up to 91% of patients in the United States remain undiagnosed, and those diagnosed often receive inappropriate treatment. These problems are of increasing importance because after acute COVID-19, a significant percentage of people remain ill for many months with an illness similar to ME/CFS. In 2015, the US National Academy of Medicine published new evidence-based clinical diagnostic criteria that have been adopted by the US Centers for Disease Control and Prevention. Furthermore, the United States and other governments as well as major health care organizations have recently withdrawn graded exercise and cognitive-behavioral therapy as the treatment of choice for patients with ME/CFS. Recently, 21 clinicians specializing in ME/CFS convened to discuss best clinical practices for adults affected by ME/CFS. This article summarizes their top recommendations for generalist and specialist health care providers based on recent scientific progress and decades of clinical experience. There are many steps that clinicians can take to improve the health, function, and quality of life of those with ME/CFS, including those in whom ME/CFS develops after COVID-19. Patients with a lingering illness that follows acute COVID-19 who do not fully meet criteria for ME/CFS may also benefit from these approaches.",
          "authors": [
            "Lucinda Bateman",
            "Alison C Bested",
            "Hector F Bonilla"
          ],
          "year": "2021",
          "journal": "Mayo Clinic proceedings",
          "doi": "10.1016/j.mayocp.2021.07.004",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34454716/"
        },
        {
          "pmid": "33856167",
          "title": "Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders are the most common symptomatic joint hypermobility conditions seen in clinical practice. The 2017 International Classification of the Ehlers-Danlos syndromes replaced previous terms for symptomatic joint hypermobility with hypermobile EDS and introduced the term hypermobility spectrum disorders for patients not meeting diagnostic criteria for hypermobile EDS. Both are diagnosed by applying the 2017 diagnostic criteria, which also excludes other less common conditions presenting with joint hypermobility such as other forms of EDS and heritable connective tissue disorders. Hypermobile EDS is inherited in an autosomal dominant pattern, but it does not have a known genetic mutation to help with diagnosis. Clinical features of hypermobile EDS include joint hypermobility, skin findings, and joint pains or recurrent dislocations. Hypermobile EDS and, less commonly, hypermobility spectrum disorders may also be associated with several extra-articular symptoms, including anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction. The central goals of therapy are managing symptoms, preventing joint injury, and educating patients about their condition. Based on limited evidence, patients with hypermobile EDS/hypermobility spectrum disorders may benefit from physical and occupational therapy, psychological support, and self-management. Primary care physicians play a key role not only in initial recognition, diagnosis, and patient education, but by virtue of their ongoing relationship they can also help oversee and coordinate the multidisciplinary team many of these patients require.",
          "authors": [
            "Kenneth S Yew",
            "Kara A Kamps-Schmitt",
            "Robyn Borge"
          ],
          "year": "2021",
          "journal": "American family physician",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/33856167/"
        },
        {
          "pmid": "34312277",
          "title": "Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care.",
          "abstract": "Hypermobility spectrum disorders (HSDs) encompass an array of connective tissue disorders characterized by joint instability and chronic pain. Fatigue and other systemic symptoms that affect daily functioning may occur, as well. Accurate data on incidence and prevalence of HSDs is hampered by lack of awareness of these conditions and the wide heterogeneity of their clinical presentation. Identifying which type of HSD is present is important in guiding appropriate care. In particular, making the diagnosis of hypermobile Ehlers-Danlos syndrome (hEDS) is important, as individuals with hEDS may be at risk for more significant multisystem involvement. Diagnostic criteria for hEDS include measures of joint hypermobility, skin and other connective tissue findings, and lack of evidence of a different type of Ehlers-Danlos syndrome. Beyond accurate diagnosis, HSDs pose many challenges for primary care providers, as ongoing patient education, patient empowerment, and coordination of a multidisciplinary treatment team are integral to proper care. This article describes the incidence and prevalence, pathophysiology, diagnosis, and management of HSDs, including clinical cases exemplifying how joint hypermobility might present within a primary care setting.",
          "authors": [
            "Karina Atwell",
            "William Michael",
            "Jared Dubey"
          ],
          "year": "2021",
          "journal": "Journal of the American Board of Family Medicine : JABFM",
          "doi": "10.3122/jabfm.2021.04.200374",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34312277/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            },
            {
              "percentage": 57.0,
              "context": "ases. hypermobility has been detected in up to 30-57% of patients with myalgic encephalomyelitis/chronic fatigue sy"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "knee pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.046,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 18,
      "frequency": 0.054474708171206226,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 3,
      "papers": [
        {
          "pmid": "34040661",
          "title": "Increased incidence of acute patellar dislocations and patellar instability surgical procedures across the United States in paediatric and adolescent patients.",
          "abstract": "Patellofemoral instability is a common cause of knee pain and dysfunction in paediatric and adolescent patients. The purpose of the study was to evaluate the frequency of patellar dislocations seen in emergency departments (EDs) and the rates of surgical procedures for patellar instability at paediatric hospitals in the United States between 2004 and 2014. The Pediatric Health Information System database was queried for all paediatric patients who underwent surgery for patellar instability or were seen in the ED for acute patellar dislocation between 2004 and 2014. This was compared with the annual numbers of overall orthopaedic surgical procedures. Between 2004 and 2014, there were 3481 patellar instability procedures and 447 285 overall orthopaedic surgical procedures performed at the included institutions, suggesting a rate of 7.8 per 1000 orthopaedic surgeries. An additional 5244 patellar dislocations treated in EDs were identified. Between 2004 and 2014, the number of patellar instability procedures increased 2.1-fold (95% confidence interval (CI) 1.4 to 3.0), while orthopaedic surgical procedures increased 1.7-fold (95% CI 1.3 to 2.0), suggesting a 1.2-fold relative increase in patellar instability procedures, compared with total paediatric orthopaedic surgeries. This study shows a significant rise in the rate of acute patellar instability treatment events in paediatric and adolescent patients across the country. Surgery for patellar instability also increased over the study period, though only slightly more than the rate of all paediatric orthopaedic surgical procedures. This may suggest that increasing youth sports participation may be leading to a spectrum of increasing injuries and associated surgeries in children. IV.",
          "authors": [
            "Kelly H McFarlane",
            "Ryan P Coene",
            "Lanna Feldman"
          ],
          "year": "2021",
          "journal": "Journal of children's orthopaedics",
          "doi": "10.1302/1863-2548.15.200225",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34040661/"
        },
        {
          "pmid": "34741592",
          "title": "Fascial thickness and stiffness in hypermobile Ehlers-Danlos syndrome.",
          "abstract": "There is a high prevalence of myofascial pain in people with hypermobile Ehlers-Danlos Syndrome (hEDS). The fascial origin of pain may correspond to changes in the extracellular matrix. The objective of this study was to investigate structural changes in fascia in hEDS. A series of 65 patients were examined prospectively-26 with hEDS, and 39 subjects with chronic neck, knee, or back pain without hEDS. The deep fascia of the sternocleidomastoid, iliotibial tract, and iliac fascia were examined with B-mode ultrasound and strain elastography, and the thicknesses were measured. Stiffness (strain index) was measured semi-quantitatively using elastography comparing fascia to muscle. Differences between groups were compared using one-way analysis of variance. hEDS subjects had a higher mean thickness in the deep fascia of the sternocleidomastoid compared with non-hEDS subjects. There was no significant difference in thickness of the iliac fascia and iliotibial tract between groups. Non-hEDS subjects with pain had a higher strain index (more softening of the fascia with relative stiffening of the muscle) compared with hEDS subjects and non-hEDS subjects without back or knee pain. In myofascial pain, softening of the fascia may occur from increase in extracellular matrix content and relative increase in stiffness of the muscle; this change is not as pronounced in hEDS.",
          "authors": [
            "Tina J Wang",
            "Antonio Stecco"
          ],
          "year": "2021",
          "journal": "American journal of medical genetics. Part C, Seminars in medical genetics",
          "doi": "10.1002/ajmg.c.31948",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34741592/"
        },
        {
          "pmid": "25278815",
          "title": "Proprioceptive acuity into knee hypermobile range in children with joint hypermobility syndrome.",
          "abstract": "Children with Joint Hypermobility Syndrome (JHS) have reduced knee joint proprioceptive acuity compared to peers. Altered proprioception at end of range in individuals with JHS is hypothesised to contribute to recurrent joint injuries and instability. This study aims to provide the first objective comparison of functional knee joint proprioceptive acuity in hyperextension range compared to early flexion range in children with JHS. Active, weight-bearing knee joint proprioceptive acuity in both hyperextension and early flexion range was tested with a purpose-built device. Proprioceptive acuity was measured using the psychophysical method of constant stimuli to determine ability to discriminate between the extents of paired active movements made to physical stops. The smallest difference in knee range of motion that the child is able to correctly judge on at least 75% of occasions, the Just Noticeable Difference (JND), was calculated using Probit analysis. Knee pain, muscle strength, amount of physical activity and patient demographic data were collected. Twenty children aged 8-16 years with JHS and hypermobile knees participated. Eleven children demonstrated better proprioceptive acuity in flexion, and 9 in hyperextension (z‚Äâ=‚Äâ0.45, p‚Äâ=‚Äâ0.63). Matched pairs t-test found no significant difference in children's ability to discriminate between the same extents of movement in the hyperextension or flexion directions (mean JND difference 0.11¬∞, 95% CI -0.26¬∞ - 0.47¬∞, p‚Äâ=‚Äâ0.545). However, 3 children could not discriminate movements in hyperextension better than chance. Proprioceptive acuity scores were positively correlated between the two directions of movement (r‚Äâ=‚Äâ0.55, p‚Äâ=‚Äâ0.02), with no significant correlations found between proprioceptive acuity and age, degree of hypermobility, muscle strength, pain level, amount of physical activity or body mass index centile (r‚Äâ=‚Äâ-0.35 to -0.03, all p ‚â•‚Äâ0.13). For a group of children with JHS involving hypermobile knees, there was no significant difference between knee joint proprioceptive acuity in early flexion and in hypermobile range when measured by a functional, active, weight-bearing test. Therefore, when implementing a proprioceptive training programme, clinicians should focus training throughout knee range, including into hyperextension. Further research is needed to determine factors contributing to pain and instability in hypermobile range.",
          "authors": [
            "Verity Pacey",
            "Roger D Adams",
            "Louise Tofts"
          ],
          "year": "2014",
          "journal": "Pediatric rheumatology online journal",
          "doi": "10.1186/1546-0096-12-40",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25278815/"
        }
      ],
      "prevalence_data": []
    }
  },
  {
    "symptom": "chronic pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.04,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 21,
      "frequency": 0.0622568093385214,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 7,
      "papers": [
        {
          "pmid": "28967365",
          "title": "Hypermobility, the Ehlers-Danlos syndromes and chronic pain.",
          "abstract": "Chronic widespread pain is a common complaint among individuals affected by generalised joint hypermobility. In the absence of other conditions that cause chronic pain, these individuals are usually diagnosed with joint hypermobility syndrome (JHS). JHS is a multifactorial trait with a strong genetic basis, but no specific genetic markers. Clinical overlap of JHS is seen with heritable connective tissue disorders, particularly with the Ehlers-Danlos syndrome, hypermobile type (hEDS). The Ehlers-Danlos syndromes (EDS) comprise a heterogeneous group of rare monogenic conditions that are characterised by joint hypermobility, skin and vascular fragility and generalised connective tissue friability, and are caused by genetic defects in an array of extracellular matrix genes. The genetic basis of hEDS remains however unknown, in contrast to other well-described EDS subtypes. In view of the considerable clinical overlap with JHS, many consider it and hEDS to be a single clinical entity. Clinical experience and a limited number of clinical studies show that chronic pain also is common in EDS patients, especially in hEDS. The specific underlying causes and mechanisms of pain in JHS and EDS remain poorly understood. Factors likely contributing to the generation and chronicity of pain include nociceptive pain, directly based on structural changes in affected joints, muscle and connective tissue; neuropathic pain; impaired proprioception and muscle weakness; and central sensitisation. These mechanisms are not mutually exclusive, and likely more than one mechanism may be present. Furthermore, anxiety, depression, and other variables may influence the phenotype. Chronic pain in JHS and EDS patients often is inadequately controlled by traditional analgesics and physical therapy. In view of the high prevalence of these underrecognised conditions, future studies addressing the nature and mediators of chronic pain are needed in order to potentially identify novel targets for therapeutic intervention and optimise treatment.",
          "authors": [
            "Delfien Syx",
            "Inge De Wandele",
            "Lies Rombaut"
          ],
          "year": "2017",
          "journal": "Clinical and experimental rheumatology",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/28967365/"
        },
        {
          "pmid": "33856167",
          "title": "Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders are the most common symptomatic joint hypermobility conditions seen in clinical practice. The 2017 International Classification of the Ehlers-Danlos syndromes replaced previous terms for symptomatic joint hypermobility with hypermobile EDS and introduced the term hypermobility spectrum disorders for patients not meeting diagnostic criteria for hypermobile EDS. Both are diagnosed by applying the 2017 diagnostic criteria, which also excludes other less common conditions presenting with joint hypermobility such as other forms of EDS and heritable connective tissue disorders. Hypermobile EDS is inherited in an autosomal dominant pattern, but it does not have a known genetic mutation to help with diagnosis. Clinical features of hypermobile EDS include joint hypermobility, skin findings, and joint pains or recurrent dislocations. Hypermobile EDS and, less commonly, hypermobility spectrum disorders may also be associated with several extra-articular symptoms, including anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction. The central goals of therapy are managing symptoms, preventing joint injury, and educating patients about their condition. Based on limited evidence, patients with hypermobile EDS/hypermobility spectrum disorders may benefit from physical and occupational therapy, psychological support, and self-management. Primary care physicians play a key role not only in initial recognition, diagnosis, and patient education, but by virtue of their ongoing relationship they can also help oversee and coordinate the multidisciplinary team many of these patients require.",
          "authors": [
            "Kenneth S Yew",
            "Kara A Kamps-Schmitt",
            "Robyn Borge"
          ],
          "year": "2021",
          "journal": "American family physician",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/33856167/"
        },
        {
          "pmid": "34312277",
          "title": "Diagnosis and Management of Hypermobility Spectrum Disorders in Primary Care.",
          "abstract": "Hypermobility spectrum disorders (HSDs) encompass an array of connective tissue disorders characterized by joint instability and chronic pain. Fatigue and other systemic symptoms that affect daily functioning may occur, as well. Accurate data on incidence and prevalence of HSDs is hampered by lack of awareness of these conditions and the wide heterogeneity of their clinical presentation. Identifying which type of HSD is present is important in guiding appropriate care. In particular, making the diagnosis of hypermobile Ehlers-Danlos syndrome (hEDS) is important, as individuals with hEDS may be at risk for more significant multisystem involvement. Diagnostic criteria for hEDS include measures of joint hypermobility, skin and other connective tissue findings, and lack of evidence of a different type of Ehlers-Danlos syndrome. Beyond accurate diagnosis, HSDs pose many challenges for primary care providers, as ongoing patient education, patient empowerment, and coordination of a multidisciplinary treatment team are integral to proper care. This article describes the incidence and prevalence, pathophysiology, diagnosis, and management of HSDs, including clinical cases exemplifying how joint hypermobility might present within a primary care setting.",
          "authors": [
            "Karina Atwell",
            "William Michael",
            "Jared Dubey"
          ],
          "year": "2021",
          "journal": "Journal of the American Board of Family Medicine : JABFM",
          "doi": "10.3122/jabfm.2021.04.200374",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34312277/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            }
          ]
        },
        {
          "pmid": "28186390",
          "title": "Pain management in the Ehlers-Danlos syndromes.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "and may be severe. according to one study, nearly 90% of patients report some form of chronic pain. pain, which is"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "gastrointestinal issues",
    "evidence_tier": 4,
    "tier_label": "‚ö†Ô∏è Emerging Pattern",
    "surprise_score": 0.039,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 14,
      "frequency": 0.042801556420233464,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 2,
      "papers": [
        {
          "pmid": "38748660",
          "title": "Management of childbearing with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A scoping review and expert co-creation of evidence-based clinical guidelines.",
          "abstract": "To co-create expert guidelines for the management of pregnancy, birth, and postpartum recovery in the context of hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD). Scoping Review and Expert Co-creation. United Kingdom, United States of America, Canada, France, Sweden, Luxembourg, Germany, Italy, and the Netherlands. Co-creators (n = 15) included expertise from patients and clinicians from the International Consortium on the Ehlers-Danlos syndromes and Hypermobility Spectrum Disorders, facilitated by the Ehlers-Danlos Society. A scoping review using Embase, Medline, the Cochrane Central Register of Controlled Trials and CINHAL was conducted from May 2022 to September 2023. Articles were included if they reported primary research findings in relation to childbearing with hEDS/HSD, including case reports. No language limitations were placed on our search, and our team had the ability to translate and screen articles retrieved in English, French, Spanish, Italian, Russian, Swedish, Norwegian, Dutch, Danish, German, and Portuguese. The Mixed Methods Appraisal Tool was used to assess bias and quality appraise articles selected. The co-creation of guidelines was based on descriptive evidence synthesis along with practical and clinical experience supported by patient and public involvement activities. Primary research studies (n = 14) and case studies (n = 21) including a total of 1,260,317 participants informed the co-creation of guidelines in four overarching categories: 1) Preconceptual: conception and screening, 2) Antenatal: risk assessment, management of miscarriage and termination of pregnancy, gastrointestinal issues and mobility, 3) Intrapartum: risk assessment, birth choices (mode of birth and intended place of birth), mobility in labor and anesthesia, and 4) Postpartum: wound healing, pelvic health, care of the newborn and infant feeding. Guidelines were also included in relation to pain management, mental health, nutrition and the common co-morbidities of postural orthostatic tachycardia syndrome, other forms of dysautonomia, and mast cell diseases. There is limited high quality evidence available. Individualized strategies are proposed for the management of childbearing people with hEDS/HSD throughout pregnancy, birth, and the postpartum period. A multidisciplinary approach is advised to address frequently seen issues in this population such as tissue fragility, joint hypermobility, and pain, as well as common comorbidities, including dysautonomia and mast cell diseases.",
          "authors": [
            "Sally Pezaro",
            "Isabelle Brock",
            "Maggie Buckley"
          ],
          "year": "2024",
          "journal": "PloS one",
          "doi": "10.1371/journal.pone.0302401",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38748660/"
        },
        {
          "pmid": "36600979",
          "title": "Gender dysphoria in adolescents with Ehlers-Danlos syndrome.",
          "abstract": "Ehlers-Danlos Syndrome represents a family of heritable connective tissue disorders that include joint hypermobility, tissue fragility, and skin hyperextensibility. Ehlers-Danlos Syndrome presents with clinical sequela across multiple body systems that require multidisciplinary care. Little is known about adolescents with Ehlers-Danlos Syndrome who are transgender and gender diverse. To date, there have been no reports of transgender and gender diverse youth in pediatric patients with Ehlers-Danlos Syndrome. The objective of this study was to characterize transgender and gender diverse adolescents with Ehlers-Danlos Syndrome seen in a pediatric multidisciplinary specialty clinic. A retrospective chart review was performed and it was found that 28 patients were seen in the Ehlers-Danlos Syndrome multidisciplinary clinic were reported being transgender and gender diverse. Chart review included analysis of all documents in the electronic medical record, including demographic data, gender identity, chosen pronouns, specialty care previously received for Ehlers-Danlos Syndrome, symptoms and conditions related to it, and medications. Of the 166 total adolescents seen in the pediatric multidisciplinary Ehlers-Danlos Syndrome clinic during the study period, 17% reported gender dysphoria. The average age at Ehlers-Danlos Syndrome diagnosis was 13.5‚Äâyears (range 8-17‚Äâyears). Most (61%) reported their gender identity as transgender, followed by nonbinary (14%). Most had preferred male (he/him) pronouns (47%), followed by nonbinary (they/them) pronouns (39%). The vast majority reported fatigue (75%), musculoskeletal issues (96%), psychiatric issues (86%), cardiac issues (71%), gastrointestinal issues (68%), and neurologic issues (79%). Here we report the first cohort of transgender and gender diverse adolescents in the Ehlers-Danlos syndrome population and show an association between the two. This report increases awareness for providers who care for patients with Ehlers-Danlos Syndrome. As care for those with Ehlers-Danlos Syndrome is often complex and multidisciplinary, providers should adopt practices of gender-affirming medical care that contribute to improved care and outcomes.",
          "authors": [
            "Jordan T Jones",
            "William R Black",
            "Christine N Moser"
          ],
          "year": "2022",
          "journal": "SAGE open medicine",
          "doi": "10.1177/20503121221146074",
          "url": "https://pubmed.ncbi.nlm.nih.gov/36600979/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "36600979",
          "title": "Gender dysphoria in adolescents with Ehlers-Danlos syndrome.",
          "prevalence_mentions": [
            {
              "percentage": 86.0,
              "context": "musculoskeletal issues (96%), psychiatric issues (86%), cardiac issues (71%), gastrointestinal issues ("
            },
            {
              "percentage": 71.0,
              "context": "(96%), psychiatric issues (86%), cardiac issues (71%), gastrointestinal issues (68%), and neurologic i"
            },
            {
              "percentage": 68.0,
              "context": "), cardiac issues (71%), gastrointestinal issues (68%), and neurologic issues (79%). here we report the"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "joint pain",
    "evidence_tier": 1,
    "tier_label": "üèÜ Diagnostic Criteria",
    "surprise_score": 0.034,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 20,
      "frequency": 0.0622568093385214,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 9,
      "papers": [
        {
          "pmid": "39660107",
          "title": "Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.",
          "abstract": "Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD ( Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.",
          "authors": [
            "Ashley A Darakjian",
            "Mira Bhutani",
            "DeLisa Fairweather"
          ],
          "year": "2024",
          "journal": "Rheumatology advances in practice",
          "doi": "10.1093/rap/rkae134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39660107/"
        },
        {
          "pmid": "32249022",
          "title": "Symptomatic joint hypermobility.",
          "abstract": "Joint hypermobility is relatively common and has many influences such as age, gender, training, and ethnicity among many. Joint hypermobility may be asymptomatic or symptomatic. It may also be non-syndromic or syndromic. However, \"asymptomatic\" joint hypermobility may result in repetitive use injury, alter biomechanics of joints at other body sites, or become symptomatic later in life. Symptomatic joint hypermobility can result from soft-tissue rheumatism (e.g. bursitis, tendonitis, etc.) or muscular tension pain due to muscular imbalance. Generalized joint hypermobility (GJH) can be easily assessed using a standardized, quick, in-office examination. Management is relatively straight forward once joint hypermobility is recognized using neuromuscular re-training. It is important to recognize that GJH may also be a feature of a heritable connective tissue disorder with other systemic findings. Therefore, assessing joint hypermobility in those with musculoskeletal complaints may lead to recognizing systemic manifestations and allow the appropriate management.",
          "authors": [
            "Brad T Tinkle"
          ],
          "year": "2020",
          "journal": "Best practice & research. Clinical rheumatology",
          "doi": "10.1016/j.berh.2020.101508",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32249022/"
        },
        {
          "pmid": "37847487",
          "title": "Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities.",
          "abstract": "Dysautonomia refers to the dysfunction of the autonomic nervous system and encompasses a wide variety of autonomic symptoms and disorders. The most common autonomic disorders are postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope (NCS), and orthostatic hypotension (OH), which may be encountered in clinical practice as part of a triad of dysautonomia, hypermobility spectrum disorders (HSD), and mast cell activation syndrome (MCAS). Migraine is one of the most common comorbidities of POTS, HSD, and MCAS; conversely, these conditions are also prevalent in patients with migraine, especially in those with multiple systemic symptoms, such as chronic dizziness, lightheadedness, orthostatic intolerance, joint pain, and allergic symptoms. Diagnostic criteria, pathophysiologic mechanisms, and therapeutic considerations in patients with migraine and comorbid dysautonomia, HSD, and MCAS are reviewed. Numerous studies indicate a significant overlap and shared pathophysiology in migraine, dysautonomia, HSD, and MCAS. In clinical setting, dysautonomia, HSD, and MCAS may present a diagnostic and therapeutic challenge in patients with migraine and require a high index of suspicion on the part of the neurologist. Diagnosis and treatment of these complex disorders in patients with migraine is essential to comprehensive patient-centric care, reduced symptom burden, and improved functional impairment secondary to both migraine and comorbidities.",
          "authors": [
            "Svetlana Blitshteyn"
          ],
          "year": "2023",
          "journal": "Current neurology and neuroscience reports",
          "doi": "10.1007/s11910-023-01307-w",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37847487/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "hypermobility",
    "evidence_tier": 1,
    "tier_label": "üèÜ Diagnostic Criteria",
    "surprise_score": 0.029,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 19,
      "frequency": 0.058365758754863814,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "32414079",
          "title": "Molecular Genetics and Pathogenesis of Ehlers-Danlos Syndrome and Related Connective Tissue Disorders.",
          "abstract": "Ehlers-Danlos syndromes (EDS) are a group of heritable connective tissue disorders (HCTDs) characterized by a variable degree of skin hyperextensibility, joint hypermobility and tissue fragility. The current EDS classification distinguishes 13 subtypes and 19 different causal genes mainly involved in collagen and extracellular matrix synthesis and maintenance. EDS need to be differentiated from other HCTDs with a variable clinical overlap including Marfan syndrome and related disorders, some types of skeletal dysplasia and cutis laxa. Clinical recognition of EDS is not always straightforward and for a definite diagnosis, molecular testing can be of great assistance, especially in patients with an uncertain phenotype. Currently, the major challenging task in EDS is to unravel the molecular basis of the hypermobile EDS that is the most frequent form, and for which the diagnosis is only clinical in the absence of any definite laboratory test. This EDS subtype, as well as other EDS-reminiscent phenotypes, are currently investigated worldwide to unravel the primary genetic defect and related pathomechanisms. The research articles, case report, and reviews published in this Special Issue focus on different clinical, genetic and molecular aspects of several EDS subtypes and some related disorders, offering novel findings and future research and nosological perspectives.",
          "authors": [
            "Marco Ritelli",
            "Marina Colombi"
          ],
          "year": "2020",
          "journal": "Genes",
          "doi": "10.3390/genes11050547",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32414079/"
        },
        {
          "pmid": "32629534",
          "title": "Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.",
          "abstract": "The Ehlers-Danlos syndromes (EDS) are a group of heritable, connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. There is phenotypic and genetic variation among the 13 subtypes. The initial genetic findings on EDS were related to alterations in fibrillar collagen, but the elucidation of the molecular basis of many of the subtypes revealed several genes not involved in collagen biosynthesis or structure. However, the genetic basis of the hypermobile type of EDS (hEDS) is still unknown. hEDS is the most common type of EDS and involves generalized joint hypermobility, musculoskeletal manifestations, and mild skin involvement along with the presence of several comorbid conditions. Variability in the spectrum and severity of symptoms and progression of patient phenotype likely depend on age, gender, lifestyle, and expression domains of the EDS genes during development and postnatal life. In this review, we summarize the current molecular, genetic, epidemiologic, and pathogenetic findings related to EDS with a focus on the hypermobile type.",
          "authors": [
            "Cortney Gensemer",
            "Randall Burks",
            "Steven Kautz"
          ],
          "year": "2021",
          "journal": "Developmental dynamics : an official publication of the American Association of Anatomists",
          "doi": "10.1002/dvdy.220",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32629534/"
        },
        {
          "pmid": "28306230",
          "title": "The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.",
          "abstract": "New insights into the phenotype of Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Syndrome-hypermobile type (hEDS) have raised many issues in relation to classification, diagnosis, assessment, and treatment. Within the multidisciplinary team, physical therapy plays a central role in management of individuals with hypermobility related disorders. However, many physical therapists are not familiar with the diagnostic criteria, prevalence, common clinical presentation, and management. This guideline aims to provide practitioners with the state of the art regarding the assessment and management of children, adolescents, and adults with JHS/hEDS. Due to the complexity of the symptoms in the profile of JHS/hEDS, the International Classification of Functioning, Disability and Health (ICF) is adopted as a central framework whereby the umbrella term of disability is used to encompass functions, activities and participation, as well as environmental and personal factors. The current evidence-based literature regarding the management of JHS/hEDS is limited in size and quality and there is insufficient research exploring the clinical outcomes of a number of interventions. Multicenter randomized controlled trials are warranted to assess the clinical and cost-effectiveness of interventions for children and adults. Until further multicenter trials are conducted, clinical decision-making should be based on theoretical and the current limited research evidence. For all individuals diagnosed with JHS/hEDS, international consensus and combined efforts to identify risk profiles would create a better understanding of the pathological mechanisms and the potential for optimizing health care for affected individuals. ¬© 2017 Wiley Periodicals, Inc.",
          "authors": [
            "Raoul H H Engelbert",
            "Birgit Juul-Kristensen",
            "Verity Pacey"
          ],
          "year": "2017",
          "journal": "American journal of medical genetics. Part C, Seminars in medical genetics",
          "doi": "10.1002/ajmg.c.31545",
          "url": "https://pubmed.ncbi.nlm.nih.gov/28306230/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "35750466",
          "title": "Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.",
          "prevalence_mentions": [
            {
              "percentage": 9.0,
              "context": "ion (73% vs 16%, p¬†<¬†0.001), and diarrhea (47% vs 9%, p¬†<¬†0.001) are significantly higher in hsd/heds"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "hip pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.022,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 11,
      "frequency": 0.0311284046692607,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 6,
      "papers": [
        {
          "pmid": "39031040",
          "title": "How Is Variability in Femoral and Acetabular Version Associated With Presentation Among Young Adults With Hip Pain?",
          "abstract": "Acetabular and femoral version contribute to hip pain in patients with femoroacetabular impingement (FAI) or dysplasia. However, definitions and measurement methods of femoral version have varied in different studies, resulting in different \"normal\" values being used by clinicians for what should be the same anatomic measurement. This could result in discrepant or even inappropriate treatment recommendations. In patients undergoing hip preservation surgery, (1) what is the range of acetabular and femoral version at presentation, and how much do two commonly used measurement techniques (those of Murphy and Reiker√•s) differ? (2) How are differences in acetabular and femoral version associated with clinical factors and outcomes scores at the time of presentation? This was a retrospective analysis of data gathered in a longitudinally maintained database of patients undergoing hip preservation at a tertiary care referral center. Between June 2020 and December 2021, 282 hips in 258 patients were treated for an isolated labral tear (9% [26 hips]), hip dysplasia (21% [59 hips]), FAI (52% [147 hips]), mixed FAI and dysplasia (17% [47 hips]), or pediatric deformity (slipped capital femoral head epiphysis or Perthes disease; 1% [3 hips]) with hip arthroscopy (71% [200 hips]), periacetabular osteotomy (26% [74 hips]), surgical hip dislocation (2.5% [7 hips]), or femoral derotation osteotomy (0.5% [1 hip]). We considered those with complete radiographic data (CT including the pelvis and distal femur) and patient-reported outcome scores as potentially eligible. Exclusion criteria were age younger than 18 or older than 55 years (5 hips, 3 patients), signs of hip osteoarthritis (T√∂nnis grade ‚â• 2; 0), pediatric deformity (slipped capital femoral head epiphysis or Perthes disease; 3 hips, 3 patients), previous femoral or acetabular osteotomy (2 hips, 2 patients), avascular necrosis of the femoral head (0), history of neuromuscular disorder (Ehlers-Danlos syndrome; 3 hips, 3 patients) or rheumatoid disease (ankylosing spondylitis; 1 hip, 1 patient), and when CT did not include the knees (19 hips, 19 patients). Based on these criteria, 249 hips in 227 patients were included. Of patients with bilateral symptomatic hips, one side was randomly selected for inclusion, leaving 227 hips in 227 patients for further analysis. The patients' median age (range) was 34 years (19 to 55 years), the median BMI (range) was 27 kg/m 2 (16 to 55 kg/m 2 ), and 63% (144) were female; they were treated with hip arthroscopy (in 74% [168]) or periacetabular osteotomy (in 23% [52]). Patients underwent a CT scan to measure acetabular version and femoral version using the Murphy (low < 10¬∞; normal: 10¬∞ to 25¬∞; high > 25¬∞) or Reiker√•s (low < 5¬∞; normal: 5¬∞ to 20¬∞; high > 20¬∞) technique. The McKibbin index was calculated (low: < 20¬∞; normal: 20¬∞ to 50¬∞; high > 50¬∞). Based on the central acetabular version and femoral version as measured by Murphy, hips were grouped according to their rotational profile into four groups: unstable rotational profile: high (high acetabular version with high femoral version) or moderate (high acetabular version with normal femoral version or normal acetabular version with high femoral version); normal rotational profile (normal acetabular version with femoral version); compensatory rotational profile (low acetabular version with high femoral version or high acetabular version with low femoral version); and impingement rotational profile (low acetabular version with low femoral version): high (low acetabular version with low femoral version) or moderate (low acetabular version with normal femoral version or normal acetabular version with low femoral version). Radiographic assessments were manually performed on digitized images by two orthopaedic residents, and 25% of randomly selected measurements were repeated by the senior author, a fellowship-trained hip preservation and arthroplasty surgeon. Interobserver and intraobserver reliabilities were calculated using the correlation coefficient with a two-way mixed model, showing excellent agreement for Murphy technique measurements (intraclass correlation coefficient 0.908 [95% confidence interval 0.80 to 0.97]) and Reiker√•s technique measurements (ICC 0.938 [95% CI 0.81 to 0.97]). Patient-reported measures were recorded using the International Hip Outcome Tool (iHOT-33) (0 to 100; worse to best). The mean acetabular version was 18¬∞ ¬± 6¬∞, and mean femoral version was 24¬∞ ¬± 12¬∞ using the Murphy technique and 12¬∞ ¬± 11¬∞ with the Reiker√•s method. Eighty percent (181 of 227) of hips had normal acetabular version, 42% (96 of 227) to 63% (142 to 227) had normal femoral version per Murphy and Reiker√•s, respectively, and 67% (152 to 227) had a normal McKibbin index. Patients with an impingement profile (low acetabular version or femoral version) were older (39 ¬± 9 years) than patients with an unstable (high acetabular version or femoral version; 33 ¬± 9 years; p = 0.004), normal (33 ¬± 9 years; p = 0.02), or compensatory (high acetabular version with low femoral version or vice versa; 33 ¬± 7 years; p = 0.08) rotational profile. Using the Murphy technique, femoral version was 12¬∞ greater than with the Reiker√•s method (R 2 0.85; p < 0.001). There were no differences in iHOT-33 score between different groups (impingement: 32 ¬± 17 versus normal 35 ¬± 21 versus compensated: 34 ¬± 20 versus unstable: 31 ¬± 17; p = 0.40). Variability in femoral version is twice as large as acetabular version. Patients with an impingement rotational profile were older than patients with a normal, compensatory, or unstable profile, indicating there are other variables not yet fully accounted for that lead to earlier pain and presentation in these groups. Important differences exist between measurement methods. This study shows that different measurement methods for femoral anteversion result in different numbers; if other authors compare their results to those of other studies, they should use equations such as the one suggested in this study. Level III, prognostic study.",
          "authors": [
            "Jeroen C F Verhaegen",
            "Zoe Kerhoulas",
            "Michaela Burke"
          ],
          "year": "2024",
          "journal": "Clinical orthopaedics and related research",
          "doi": "10.1097/CORR.0000000000003076",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39031040/"
        },
        {
          "pmid": "40471833",
          "title": "Hip Microinstability: New Concepts and Comprehensive Imaging Evaluation.",
          "abstract": "Hip instability is defined generally as extraphysiologic femoroacetabular motion classically observed as a sequela of prior trauma, hip arthroplasty, and developmental hip dysplasia. However, new concepts regarding subtle forms of hip instability have gained importance in recent discussions and literature with the emergence of the term ",
          "authors": [
            "J√∫lio B Guimar√£es",
            "Pedro H C Arruda",
            "Luis Cerezal"
          ],
          "year": "2025",
          "journal": "Radiographics : a review publication of the Radiological Society of North America, Inc",
          "doi": "10.1148/rg.240134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40471833/"
        },
        {
          "pmid": "39126670",
          "title": "Nonpelvic comorbid symptoms of 45 patients with pain of pelvic venous origin, before and after treatment.",
          "abstract": "To report the prevalence and severity of nonpelvic symptoms for patients with venous-origin chronic pelvic pain (VO-CPP) and to describe outcomes after pelvic vein stenting and embolization. We retrospectively reviewed outcomes of 45 women with VO-CPP who underwent treatment with iliac vein stenting and/or embolization. Patients completed symptom-severity questionnaires before and after treatment that assessed for pelvic pain, and multiple other symptoms, including brain fog, anxiety, depression, musculoskeletal pain, fatigue, migraines and more. Patient age ranged from 18 to 65 years. The prevalence of common symptoms was as follows: migraines, 69%; brain fog, 76%; anxiety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal bloating, 82%. After treatment, most symptom scores improved by more than 50%; exceptions were excessive sweating (41% improvement) and bloating (47% improvement). Prevalence of individual symptoms that bundle into POTS ranged from 29% to 76%, where symptom improvement ranged from 23% to 59% after treatment. Overlapping individual symptoms characteristic of fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) were present in 64% to 82% of patients and all improved by 49% to 63% after treatment. Pelvic venous flow abnormality is linked causally to a spectrum of interrelated symptoms, of which many can be bundled into named syndromes of unknown cause. With catheter- based treatment of pelvic venous pooling, nonpelvic symptom and syndrome scores improved.",
          "authors": [
            "Steven J Smith",
            "B Holly Smith",
            "Michael J Sichlau"
          ],
          "year": "2025",
          "journal": "Phlebology",
          "doi": "10.1177/02683555241273109",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39126670/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39126670",
          "title": "Nonpelvic comorbid symptoms of 45 patients with pain of pelvic venous origin, before and after treatment.",
          "prevalence_mentions": [
            {
              "percentage": 58.0,
              "context": "migraines, 69%; brain fog, 76%; anxiety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 6"
            },
            {
              "percentage": 64.0,
              "context": "fog, 76%; anxiety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%;"
            },
            {
              "percentage": 73.0,
              "context": "ety attacks, 58%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal"
            },
            {
              "percentage": 62.0,
              "context": "%; excess sweating, 64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal bloating, 82%."
            },
            {
              "percentage": 76.0,
              "context": "64%; hip pain, 73%; diarrhea, 62%; constipation, 76%; and abdominal bloating, 82%. after treatment, mo"
            }
          ]
        },
        {
          "pmid": "40199562",
          "title": "Test characteristics of clinical findings and clinical decision rules for the diagnosis of septic arthritis in children with an acute limp presenting to the emergency department: a prospective observational study.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "5.0 to 38.5), signs of systemic disease (or 20.5, 95% ci 6.2 to 67.7), hip pain (or 3.8, 95% ci 1.2 to 1"
            },
            {
              "percentage": 95.0,
              "context": "(or 20.5, 95% ci 6.2 to 67.7), hip pain (or 3.8, 95% ci 1.2 to 11.7) and presence of fever (or 5.1, 95%"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "back pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.021,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 14,
      "frequency": 0.042801556420233464,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "34741592",
          "title": "Fascial thickness and stiffness in hypermobile Ehlers-Danlos syndrome.",
          "abstract": "There is a high prevalence of myofascial pain in people with hypermobile Ehlers-Danlos Syndrome (hEDS). The fascial origin of pain may correspond to changes in the extracellular matrix. The objective of this study was to investigate structural changes in fascia in hEDS. A series of 65 patients were examined prospectively-26 with hEDS, and 39 subjects with chronic neck, knee, or back pain without hEDS. The deep fascia of the sternocleidomastoid, iliotibial tract, and iliac fascia were examined with B-mode ultrasound and strain elastography, and the thicknesses were measured. Stiffness (strain index) was measured semi-quantitatively using elastography comparing fascia to muscle. Differences between groups were compared using one-way analysis of variance. hEDS subjects had a higher mean thickness in the deep fascia of the sternocleidomastoid compared with non-hEDS subjects. There was no significant difference in thickness of the iliac fascia and iliotibial tract between groups. Non-hEDS subjects with pain had a higher strain index (more softening of the fascia with relative stiffening of the muscle) compared with hEDS subjects and non-hEDS subjects without back or knee pain. In myofascial pain, softening of the fascia may occur from increase in extracellular matrix content and relative increase in stiffness of the muscle; this change is not as pronounced in hEDS.",
          "authors": [
            "Tina J Wang",
            "Antonio Stecco"
          ],
          "year": "2021",
          "journal": "American journal of medical genetics. Part C, Seminars in medical genetics",
          "doi": "10.1002/ajmg.c.31948",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34741592/"
        },
        {
          "pmid": "26929631",
          "title": "Low-back pain at the emergency department: still not being managed?",
          "abstract": "Low-back pain (LBP) affects about 40% of people at some point in their lives. In the presence of \"red flags\", further tests must be done to rule out underlying problems; however, biomedical imaging is currently overused. LBP involves large in-hospital and out-of-hospital economic costs, and it is also the most common musculoskeletal disorder seen in emergency departments (EDs). This retrospective observational study enrolled 1,298 patients admitted to the ED, including all International Classification of Diseases 10 diagnosis codes for sciatica, lumbosciatica, and lumbago. We collected patients' demographic data, medical history, lab workup and imaging performed at the ED, drugs administered at the ED, ED length of stay (LOS), numeric rating scale pain score, admission to ward, and ward LOS data. Thereafter, we performed a cost analysis. Mean numeric rating scale scores were higher than 7/10. Home medication consisted of no drug consumption in up to 90% of patients. Oxycodone-naloxone was the strong opioid most frequently prescribed for the home. Once at the ED, nonsteroidal anti-inflammatory drugs and opiates were administered to up to 72% and 42% of patients, respectively. Imaging was performed in up to 56% of patients. Mean ED LOS was 4 hours, 14 minutes. A total of 43 patients were admitted to a ward. The expense for each non-ward-admitted patient was approximately ‚Ç¨200 in the ED, while the mean expense for ward-admitted patients was ‚Ç¨9,500, with a mean LOS of 15 days. There is not yet a defined therapeutic care process for the patient with LBP with clear criteria for an ED visit. It is to this end that we need a clinical pathway for the prehospital management of LBP syndrome and consequently for an in-hospital time-saving therapeutic approach to the patient.",
          "authors": [
            "Alessandro Rizzardo",
            "Luca Miceli",
            "Rym Bednarova"
          ],
          "year": "2016",
          "journal": "Therapeutics and clinical risk management",
          "doi": "10.2147/TCRM.S91898",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26929631/"
        },
        {
          "pmid": "35738227",
          "title": "Opioid safety initiative associated with decreased emergency department opioid prescribing.",
          "abstract": "The opioid abuse epidemic has focused attention on efforts to decrease opioid prescribing. Although education and feedback interventions are potential levers to affect opioid prescribing, their incremental contribution against a background of declining opioid prescriptions is unclear. We retrospectively evaluated opioid prescribing frequencies after an emergency physician-specific education and feedback initiative in an integrated health care system. We evaluated opioid prescriptions for adult patients discharged from 21 emergency departments (EDs) between January 1, 2014, and December 31, 2018. Applying interrupted time series methodology to account for time trends, we analyzed pre- to postintervention changes in prescribing of any opioid and in opioid prescriptions for greater than 20 tablets. We studied all ED visits, visits for back pain and acute extremity fracture, and visits stratified by physicians with high vs low frequency of opioid prescribing. We identified patient, physician, and visit characteristics associated with postintervention ED opioid prescriptions (2018). Of 1.01 million preintervention and 1.59 million postintervention ED visits, after adjusting for the background trend over time, the intervention was associated with a 3.4% decrease in frequency of opioid prescriptions post intervention (95% CI, -4% to -2.8%), with similar decreases in high-quantity prescriptions (>‚Äâ20 tablets) and back pain- and acute extremity fracture-related ED visits. Postintervention adjusted analyses indicated no significant association between opioid prescription and race/ethnicity or prior history of opioid abuse. The ED Opioid Safety Initiative was associated with a near-term decrease in multiple categories of opioid prescribing, including for selected subgroups of common painful conditions.",
          "authors": [
            "Mamata Kene",
            "Sunil Bhopale",
            "Abigail Eaton"
          ],
          "year": "2022",
          "journal": "The American journal of managed care",
          "doi": "10.37765/ajmc.2022.89158",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35738227/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "26929631",
          "title": "Low-back pain at the emergency department: still not being managed?",
          "prevalence_mentions": [
            {
              "percentage": 40.0,
              "context": "low-back pain (lbp) affects about 40% of people at some point in their lives. in the presen"
            }
          ]
        },
        {
          "pmid": "33963027",
          "title": "Chronic Low Back Pain Occurring in Association With Hypermobility Spectrum Disorder and Ehlers-Danlos Syndrome.",
          "prevalence_mentions": [
            {
              "percentage": 50.0,
              "context": "ile eds population have been reported to be up to 50%. when hypermobility and chronic lumbar back pain"
            }
          ]
        },
        {
          "pmid": "35229394",
          "title": "Low back pain presentations to rural, regional, and metropolitan emergency departments.",
          "prevalence_mentions": [
            {
              "percentage": 6.0,
              "context": "or outer regional eds. re-presentation rates were 6% in major cities, 8.8% in inner regional eds and 11"
            },
            {
              "percentage": 8.8,
              "context": "s. re-presentation rates were 6% in major cities, 8.8% in inner regional eds and 11.8% in outer regional"
            },
            {
              "percentage": 11.8,
              "context": "% in major cities, 8.8% in inner regional eds and 11.8% in outer regional eds. admission rates were 20.4%,"
            },
            {
              "percentage": 20.4,
              "context": "11.8% in outer regional eds. admission rates were 20.4%, 15.8% and 18.8%, respectively. this study descri"
            },
            {
              "percentage": 15.8,
              "context": "n outer regional eds. admission rates were 20.4%, 15.8% and 18.8%, respectively. this study describes lbp"
            },
            {
              "percentage": 18.8,
              "context": "gional eds. admission rates were 20.4%, 15.8% and 18.8%, respectively. this study describes lbp presentat"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "anxiety",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.019,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 11,
      "frequency": 0.0311284046692607,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 8,
      "papers": [
        {
          "pmid": "29644987",
          "title": "Preventing and managing workplace violence against healthcare workers in Emergency Departments.",
          "abstract": "Healthcare workers (HCWs) employed in Emergency Departments (EDs) frequently face with patients becoming violent because of long wait or diseases or under the influence of alcohol or drugs. Globally, workplace violence (WPV) in EDs is a major challenge to safety for HCWs, involving significant consequences to the victims, patients, and healthcare organizations. We reviewed the current literature with the aim to explore the topics focused on and to detect new evidences about approaching the issue of WPV toward HCWs in EDs. A search for articles regarding WPV toward HCWs employed in EDs and published from January 2007 through December 2017 was performed; using predetermined criteria for inclusion, selected articles were reviewed and qualitatively assessed for the aims of the review. We found 60 papers which matched our inclusion criteria; the topics, discussed in order of frequency from highest to lowest, were: \"Risk Assessment\", \"Occurrence Rates\", \"Risk Management\", and \"Physical/non Physical Consequences\". Dementia, schizophrenia, anxiety, acute stress reaction, suicidal ideation, and alcohol and drug intoxication were found as predictors of physical violence perpetrated by patients against HCWs. A strategic way to the effective management of WPV should prioritize training courses focused on: constructing HCW-patient relationship, improving the workers' communication skills, accurate reporting of each violent incident, and improving the labor context through management commitment and employee involvement in WPV prevention programs. A special effort is required in implementing workplace design effective in minimizing stressful conditions in waiting rooms which turned out to be the most frequent site of assaults.",
          "authors": [
            "Gabriele D'Ettorre",
            "Vincenza Pellicani",
            "Mauro Mazzotta"
          ],
          "year": "2018",
          "journal": "Acta bio-medica : Atenei Parmensis",
          "doi": "10.23750/abm.v89i4-S.7113",
          "url": "https://pubmed.ncbi.nlm.nih.gov/29644987/"
        },
        {
          "pmid": "33856167",
          "title": "Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders are the most common symptomatic joint hypermobility conditions seen in clinical practice. The 2017 International Classification of the Ehlers-Danlos syndromes replaced previous terms for symptomatic joint hypermobility with hypermobile EDS and introduced the term hypermobility spectrum disorders for patients not meeting diagnostic criteria for hypermobile EDS. Both are diagnosed by applying the 2017 diagnostic criteria, which also excludes other less common conditions presenting with joint hypermobility such as other forms of EDS and heritable connective tissue disorders. Hypermobile EDS is inherited in an autosomal dominant pattern, but it does not have a known genetic mutation to help with diagnosis. Clinical features of hypermobile EDS include joint hypermobility, skin findings, and joint pains or recurrent dislocations. Hypermobile EDS and, less commonly, hypermobility spectrum disorders may also be associated with several extra-articular symptoms, including anxiety disorders, chronic pain, fatigue, orthostatic intolerance, functional gastrointestinal disorders, and pelvic and bladder dysfunction. The central goals of therapy are managing symptoms, preventing joint injury, and educating patients about their condition. Based on limited evidence, patients with hypermobile EDS/hypermobility spectrum disorders may benefit from physical and occupational therapy, psychological support, and self-management. Primary care physicians play a key role not only in initial recognition, diagnosis, and patient education, but by virtue of their ongoing relationship they can also help oversee and coordinate the multidisciplinary team many of these patients require.",
          "authors": [
            "Kenneth S Yew",
            "Kara A Kamps-Schmitt",
            "Robyn Borge"
          ],
          "year": "2021",
          "journal": "American family physician",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/33856167/"
        },
        {
          "pmid": "28967365",
          "title": "Hypermobility, the Ehlers-Danlos syndromes and chronic pain.",
          "abstract": "Chronic widespread pain is a common complaint among individuals affected by generalised joint hypermobility. In the absence of other conditions that cause chronic pain, these individuals are usually diagnosed with joint hypermobility syndrome (JHS). JHS is a multifactorial trait with a strong genetic basis, but no specific genetic markers. Clinical overlap of JHS is seen with heritable connective tissue disorders, particularly with the Ehlers-Danlos syndrome, hypermobile type (hEDS). The Ehlers-Danlos syndromes (EDS) comprise a heterogeneous group of rare monogenic conditions that are characterised by joint hypermobility, skin and vascular fragility and generalised connective tissue friability, and are caused by genetic defects in an array of extracellular matrix genes. The genetic basis of hEDS remains however unknown, in contrast to other well-described EDS subtypes. In view of the considerable clinical overlap with JHS, many consider it and hEDS to be a single clinical entity. Clinical experience and a limited number of clinical studies show that chronic pain also is common in EDS patients, especially in hEDS. The specific underlying causes and mechanisms of pain in JHS and EDS remain poorly understood. Factors likely contributing to the generation and chronicity of pain include nociceptive pain, directly based on structural changes in affected joints, muscle and connective tissue; neuropathic pain; impaired proprioception and muscle weakness; and central sensitisation. These mechanisms are not mutually exclusive, and likely more than one mechanism may be present. Furthermore, anxiety, depression, and other variables may influence the phenotype. Chronic pain in JHS and EDS patients often is inadequately controlled by traditional analgesics and physical therapy. In view of the high prevalence of these underrecognised conditions, future studies addressing the nature and mediators of chronic pain are needed in order to potentially identify novel targets for therapeutic intervention and optimise treatment.",
          "authors": [
            "Delfien Syx",
            "Inge De Wandele",
            "Lies Rombaut"
          ],
          "year": "2017",
          "journal": "Clinical and experimental rheumatology",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/28967365/"
        }
      ],
      "prevalence_data": []
    }
  },
  {
    "symptom": "subluxation",
    "evidence_tier": 1,
    "tier_label": "üèÜ Diagnostic Criteria",
    "surprise_score": 0.019,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 10,
      "frequency": 0.0311284046692607,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 8,
      "papers": [
        {
          "pmid": "34845816",
          "title": "Orthopedic considerations and surgical outcomes in Ehlers-Danlos syndromes.",
          "abstract": "The Ehlers-Danlos syndromes (EDS) are a clinically and genetically heterogeneous group of connective tissue disorders with varying physical manifestations. There are no clear guidelines for addressing orthopedic concerns or reporting surgical outcomes in this population. This article reviews the literature, reports on a new study, and offers considerations prior to surgical intervention. The new study seeks to determine the effectiveness of surgical intervention in individuals with EDS. It is a retrospective chart review of 154 individuals clinically diagnosed with EDS who had orthopedic surgery >2‚Äâyears ago at Hospital for Special Surgery. A total of 120 individuals were included in the study. One hundred eleven females and 9 males underwent a total of 320 orthopedic surgeries, of which 204 surgeries had available post-operative follow-up. The average age at surgery was 38.2‚Äâyears (range: 7.6-83.3). Multiple post-operative complications (290) were reported in 91% of cases. Common complications were persistent pain/discomfort (45), continued subluxation/dislocation (20), instability (19), pain/discomfort from hardware (17), and infection (16). Our results suggest that surgical outcomes are worse for individuals with EDS compared to the general population, a finding which is similar to other studies. Complications occurred more frequently in the EDS population than the average population, suggesting that surgery should be undertaken by a multidisciplinary team of clinicians with careful pre-operative planning and full knowledge of the risks and benefits. Guidelines for the care of this unique population must be established.",
          "authors": [
            "Elizabeth A Yonko",
            "Holly M LoTurco",
            "Erin M Carter"
          ],
          "year": "2021",
          "journal": "American journal of medical genetics. Part C, Seminars in medical genetics",
          "doi": "10.1002/ajmg.c.31958",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34845816/"
        },
        {
          "pmid": "27824552",
          "title": "Ehlers-Danlos Syndrome-Hypermobility Type: A Much Neglected Multisystemic Disorder.",
          "abstract": "Ehlers-Danlos syndrome (EDS)-hypermobility type (HT) is considered to be the most common subtype of EDS and the least severe one; EDS-HT is considered to be identical to the joint hypermobility syndrome and manifests with musculoskeletal complaints, joint instability, and soft tissue overuse injury. Musculoskeletal complaints manifest with joint pain of non-inflammatory origin and/or spinal pain. Joint instability leads to dislocation or subluxation and involves peripheral joints as well as central joints, including the temporomandibular joints, sacroiliac joints, and hip joints. Soft tissue overuse injury may lead to tendonitis and bursitis without joint inflammation in most cases. Ehlers-Danlos syndrome-HT carries a high potential for disability due to recurrent dislocations and subluxations and chronic pain. Throughout the years, extra-articular manifestations have been described, including cardiovascular, autonomic nervous system, gastrointestinal, hematologic, ocular, gynecologic, neurologic, and psychiatric manifestations, emphasizing the multisystemic nature of EDS-HT. Unfortunately, EDS-HT is under-recognized and inadequately managed, leading to neglect of these patients, which may lead to severe disability that almost certainly could have been avoided. In this review article we will describe the known manifestations of the extra-articular systems.",
          "authors": [
            "Yael Gazit",
            "Giris Jacob",
            "Rodney Grahame"
          ],
          "year": "2016",
          "journal": "Rambam Maimonides medical journal",
          "doi": "10.5041/RMMJ.10261",
          "url": "https://pubmed.ncbi.nlm.nih.gov/27824552/"
        },
        {
          "pmid": "32709178",
          "title": "Ehlers-Danlos Syndrome: An Analysis of the Current Treatment Options.",
          "abstract": "Ehlers-Danlos syndrome (EDS) is a multifaceted disease that can present with a variety of types of pain. Unfortunately, both the mechanisms and treatments for pain are poorly understood. The proposed treatments for the various musculoskeletal pain syndromes in EDS have had variable success, and it becomes much more imperative to better define and evaluate the current treatment modalities in treating this debilitating disease. The purpose of this study was to investigate the currently available treatment modalities for patients with EDS and their efficacies in pain and symptom relief. Retrospective cohort study. Institutional physical medicine and rehabilitation primary care clinic. All patients were seen between January 2015 and April 2019, in which 98 patients with EDS were identified through retrospective chart review. Institutional review board approval was obtained, and all patients provided written consent to be included in the study. We reviewed various treatment modalities, including complimentary/alternative treatments, opioids/opioid-like medications, nonsteroidal antiinflammatory drugs, physical therapy, occupational therapy, muscle relaxants, neuropathic modulators, steroids, surgery/procedures, and acetaminophen. Treatment methods were extracted from individual patient charts, and efficacy was grouped into 3 categories: improvement, no effect, or worsened symptoms. The most common treatments used were complimentary/alternative treatments (n = 88). Occupational therapy and bracing were the most effective options with 70% of patients reporting improvement. Neuropathic modulators were the least well tolerated with 47% of patients reporting adverse effects. Men were a small percentage of the study. Patients were not randomized, and pain score reporting was subjective. Patient data were extracted from a single practice setting. Timing and symptom onset were not measured. There is a relative paucity of published literature regarding the various treatment methods for EDS. Although our study is able to identify positive and negative trends with certain modalities, it is vital to understand that EDS is not a uniform diagnosis among patients, and that a combination of several different treatments usually is needed for optimal symptom control. Further research and investigation are necessary to develop a comprehensive treatment database for this complex condition. Ehlers-Danlos syndrome, pain, hypermobility, arthralgia, subluxation, genetic, physical therapy, interventional pain.",
          "authors": [
            "Bo Song",
            "Peter Yeh",
            "Daniel Nguyen"
          ],
          "year": "2020",
          "journal": "Pain physician",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/32709178/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "27908650",
          "title": "Musculoskeletal Conditions in a Pediatric Population with Ehlers-Danlos Syndrome.",
          "prevalence_mentions": [
            {
              "percentage": 55.6,
              "context": "ean age 12.7 years). the most common eds subtype (55.6%) was hypermobility type. patients had between 1 a"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "dislocation",
    "evidence_tier": 1,
    "tier_label": "üèÜ Diagnostic Criteria",
    "surprise_score": 0.019,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 9,
      "frequency": 0.027237354085603113,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 6,
      "papers": [
        {
          "pmid": "26005130",
          "title": "Ehlers-Danlos syndrome in rheumatology: Diagnostic and therapeutic challenges.",
          "abstract": null,
          "authors": [
            "Salima Challal",
            "Emeline Minichiello",
            "Benoit Funalot"
          ],
          "year": "2015",
          "journal": "Joint bone spine",
          "doi": "10.1016/j.jbspin.2015.04.002",
          "url": "https://pubmed.ncbi.nlm.nih.gov/26005130/"
        },
        {
          "pmid": "39660107",
          "title": "Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.",
          "abstract": "Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD ( Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.",
          "authors": [
            "Ashley A Darakjian",
            "Mira Bhutani",
            "DeLisa Fairweather"
          ],
          "year": "2024",
          "journal": "Rheumatology advances in practice",
          "doi": "10.1093/rap/rkae134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39660107/"
        },
        {
          "pmid": "34807427",
          "title": "Connective Tissue Disorders in Domestic Animals.",
          "abstract": "Though soft tissue disorders have been recognized and described to some detail in several types of domestic animals and small mammals for some years, they remain uncommon. Because of their low prevalence, not much progress has been made not only in improved diagnosis but also in our understanding of the biochemical basis and pathogenesis of these diseases in animals. Ehlers-Danlos syndrome (EDS) described in dogs already in 1943 and later in cats has only minor impact on the well-being of the dog as its effects on skin of these animals are rather limited. The involved skin is thin and hyperextensible with easily inflicted injuries resulting in hemorrhagic wounds and atrophic scars. Joint laxity and dislocation common in people are less frequently found in dogs. No systemic complications, such as organ rupture or cardiovascular problems which have devastating consequences in people have been described in cats and dogs. The diagnosis is based on clinical presentation and on light or electron microscopic features of disorganized and fragmented collagen fibrils. Several case of bovine and ovine dermatosparaxis analogous to human Ehlers-Danlos syndrome type VIIC were found to be caused by mutations in the procollagen I N-proteinase (pnPI) or ADAMTS2 gene, though mutations in other sites are likely responsible for other types of dermatosparaxis. Cattle suffering from a form of Marfan syndrome (MFS) were described to have aortic dilatation and aneurysm together with ocular abnormalities and skeletal involvement. As in people, mutations at different sites of bovine FBN1 may be responsible for Marfan phenotype. Hereditary equine regional dermal asthenia (HERDA), or hyperelastosis cutis, has been recognized in several horse breeds as affecting primarily skin, and, occasionally, tendons. A mutation in cyclophilin B, a chaperon involved in proper folding of collagens, has been identified in some cases. Warmblood fragile foal syndrome (WFFS) is another Ehlers-Danlos-like disorder in horses, affecting primarily Warmbloods who present with skin fragility and joint hyperextensibility. Degenerative suspensory ligament desmitis (DSLD) affects primarily tendons and ligaments of certain horse breeds. Data from our laboratory showed excessive accumulation of proteoglycans in organs with high content of connective tissues. We have identified increased presence of bone morphogenetic protein 2 (BMP2) in active foci of DSLD and an abnormal form of decorin in proteoglycan deposits. Our most recent data obtained from next generation sequencing showed disturbances in expression of genes for numerous proteoglycans and collagens.",
          "authors": [
            "Jennifer Hope Roberts",
            "Jaroslava Halper"
          ],
          "year": "2021",
          "journal": "Advances in experimental medicine and biology",
          "doi": "10.1007/978-3-030-80614-9_15",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34807427/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39474185",
          "title": "Surgical management of glenohumeral instability in patients with Ehlers-Danlos syndrome/hypermobility spectrum disorder and their risk of reoperation.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "undergo arthroscopic bankart repair (aor¬†= 0.48, 95% ci [0.40, 0.58]). preoperative eds/hsd was also as"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "muscle tightness",
    "evidence_tier": 4,
    "tier_label": "‚ö†Ô∏è Emerging Pattern",
    "surprise_score": 0.016,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 0,
      "papers": [],
      "prevalence_data": []
    }
  },
  {
    "symptom": "dysautonomia",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.015,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 9,
      "frequency": 0.027237354085603113,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 9,
      "papers": [
        {
          "pmid": "40869462",
          "title": "Defining the Chronic Complexities of hEDS and HSD: A Global Survey of Diagnostic Challenges, Life-Long Comorbidities, and Unmet Needs.",
          "abstract": "",
          "authors": [
            "Victoria Daylor",
            "Molly Griggs",
            "Amy Weintraub"
          ],
          "year": "2025",
          "journal": "Journal of clinical medicine",
          "doi": "10.3390/jcm14165636",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40869462/"
        },
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive evaluations of a larger sample of hEDS patients are lacking. The objective of this study was to describe cerebrovascular, autonomic, and neuropathic features of hEDS. This retrospective case-control study was conducted at Brigham and Women's Faulkner Hospital between 2016-2023. Data from hEDS patients who completed autonomic testing and skin biopsies were analyzed. Outcome measures include validated surveys (Survey of Autonomic Functions, Neuropathy Total Symptom Score-6 (SAS)) and autonomic function testing (Valsalva maneuver, deep breathing, head-up tilt and sudomotor), cerebrovascular (cerebral blood flow velocity (CBFv) in the middle cerebral artery), respiratory (capnography), and neuropathic (skin biopsies for assessment of small fiber neuropathy) testing and inflammatory/ autoimmune markers. Total 270 hEDS patients were analyzed and compared to 29 healthy controls. Common hEDS complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastrointestinal, and pain. Orthostatic cerebral blood flow velocity was reduced in 79% of hEDS and correlated with orthostatic dizziness. The head-up tilt test revealed postural tachycardia syndrome (prevalence 33%), hypocapnic cerebral hypoperfusion (22%), orthostatic cerebral hypoperfusion syndrome (18%), and neurogenic orthostatic hypotension (9%). Widespread but mild autonomic failure was present in 90% of hEDS patients on autonomic testing. Small fiber neuropathy using structural criteria was detected in 64%, and using combined structural and functional criteria in 82%. This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread but mild autonomic failure in hEDS.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2025",
          "journal": "American journal of medicine open",
          "doi": "10.1016/j.ajmo.2025.100111",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40843452/"
        },
        {
          "pmid": "38291116",
          "title": "Mismatch between subjective and objective dysautonomia.",
          "abstract": "Autonomic symptom questionnaires are frequently used to assess dysautonomia. It is unknown whether subjective dysautonomia obtained from autonomic questionnaires correlates with objective dysautonomia measured by quantitative autonomic testing. The objective of our study was to determine correlations between subjective and objective measures of dysautonomia. This was a retrospective cross-sectional study conducted at Brigham and Women's Faulkner Hospital Autonomic Laboratory between 2017 and 2023 evaluating the patients who completed autonomic testing. Analyses included validated autonomic questionnaires [Survey of Autonomic Symptoms (SAS), Composite Autonomic Symptom Score 31 (Compass-31)] and standardized autonomic tests (Valsalva maneuver, deep breathing, sudomotor, and tilt test). The autonomic testing results were graded by a Quantitative scale for grading of cardiovascular reflexes, sudomotor tests and skin biopsies (QASAT), and Composite Autonomic Severity Score (CASS). Autonomic testing, QASAT, CASS, and SAS were obtained in 2627 patients, and Compass-31 in 564 patients. The correlation was strong between subjective instruments (SAS vs. Compass-31, r‚Äâ=‚Äâ0.74, p‚Äâ<‚Äâ0.001) and between objective instruments (QASAT vs. CASS, r‚Äâ=‚Äâ0.81, p‚Äâ<‚Äâ0.001). There were no correlations between SAS and QASAT nor between Compass-31 and CASS. There continued to be no correlations between subjective and objective instruments for selected diagnoses (post-acute sequelae of COVID-19, n‚Äâ=‚Äâ61; postural tachycardia syndrome, 211; peripheral autonomic neuropathy, 463; myalgic encephalomyelitis/chronic fatigue syndrome, 95; preload failure, 120; post-treatment Lyme disease syndrome, 163; hypermobile Ehlers-Danlos syndrome, 213; neurogenic orthostatic hypotension, 86; diabetes type II, 71, mast cell activation syndrome, 172; hereditary alpha tryptasemia, 45). The lack of correlation between subjective and objective instruments highlights the limitations of the commonly used questionnaires with some patients overestimating and some underestimating true autonomic deficit. The diagnosis-independent subjective-objective mismatch further signifies the unmet need for reliable screening surveys. Patients who overestimate the symptom burden may represent a population with idiosyncratic autonomic-like symptomatology, which needs further study. At this time, the use of autonomic questionnaires as a replacement of autonomic testing cannot be recommended.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2024",
          "journal": "Scientific reports",
          "doi": "10.1038/s41598-024-52368-x",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38291116/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "hy controls. common heds complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastroint"
            },
            {
              "percentage": 79.0,
              "context": "tatic cerebral blood flow velocity was reduced in 79% of heds and correlated with orthostatic dizziness. th"
            },
            {
              "percentage": 90.0,
              "context": "espread but mild autonomic failure was present in 90% of heds patients on autonomic testing. small fiber ne"
            }
          ]
        },
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "dizziness",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.015,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 9,
      "frequency": 0.027237354085603113,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 9,
      "papers": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive evaluations of a larger sample of hEDS patients are lacking. The objective of this study was to describe cerebrovascular, autonomic, and neuropathic features of hEDS. This retrospective case-control study was conducted at Brigham and Women's Faulkner Hospital between 2016-2023. Data from hEDS patients who completed autonomic testing and skin biopsies were analyzed. Outcome measures include validated surveys (Survey of Autonomic Functions, Neuropathy Total Symptom Score-6 (SAS)) and autonomic function testing (Valsalva maneuver, deep breathing, head-up tilt and sudomotor), cerebrovascular (cerebral blood flow velocity (CBFv) in the middle cerebral artery), respiratory (capnography), and neuropathic (skin biopsies for assessment of small fiber neuropathy) testing and inflammatory/ autoimmune markers. Total 270 hEDS patients were analyzed and compared to 29 healthy controls. Common hEDS complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastrointestinal, and pain. Orthostatic cerebral blood flow velocity was reduced in 79% of hEDS and correlated with orthostatic dizziness. The head-up tilt test revealed postural tachycardia syndrome (prevalence 33%), hypocapnic cerebral hypoperfusion (22%), orthostatic cerebral hypoperfusion syndrome (18%), and neurogenic orthostatic hypotension (9%). Widespread but mild autonomic failure was present in 90% of hEDS patients on autonomic testing. Small fiber neuropathy using structural criteria was detected in 64%, and using combined structural and functional criteria in 82%. This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread but mild autonomic failure in hEDS.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2025",
          "journal": "American journal of medicine open",
          "doi": "10.1016/j.ajmo.2025.100111",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40843452/"
        },
        {
          "pmid": "40070159",
          "title": "Validation of the Sudbury Vertigo Risk Score to risk stratify for a serious cause of vertigo.",
          "abstract": "In 2022, nearly 0.5 million Canadians visited an emergency department (ED) for dizziness, accounting for over 3.5% of all ED visits. Of these patients, only 2%-5% received a serious diagnosis. The cost of ED and inpatient care for dizziness in Canada exceeds $200 million per year, of which neuroimaging accounts for a large proportion. Over one-third of dizziness patients undergo a CT scan of the head, 96% of which are negative. Despite extensive investigation, patients discharged with a benign dizziness diagnosis have a 50-fold increased risk of being admitted to the hospital within 7‚Äâdays with a diagnosis of stroke. Our study aimed to derive a clinical risk score to guide the investigation and referral for serious causes of vertigo in ED patients. This multicenter historical cohort study was conducted over 7‚Äâyears at three university-affiliated tertiary care EDs. Patients presenting with vertigo, dizziness, or imbalance were recruited. The main outcome was an adjudicated serious diagnosis, defined as stroke, transient ischemic attack, vertebral artery dissection, or brain tumor. We estimated a sample size of 4450 patients, based on a 2% prevalence of serious outcomes, to evaluate the sensitivity with 95% confidence intervals (CIs). A total of 4559 patients were enrolled (mean age 78.1‚Äâyears, 57.8% women), with serious events occurring in 104 (2.3%) patients. The C-statistic was 0.95 (95% CI 0.92-0.98). The risk of a serious diagnosis ranged from 0% for a score of <5 to 16.7% for a score >8. Sensitivity for a serious diagnosis was 100% (95% CI 96.5%-100%) and specificity was 69.2% (95% CI 67.8%-70.51%) for a score <5. The Sudbury Vertigo Risk Score effectively identifies the risk of a serious diagnosis in patients with dizziness. Thus, it guides further investigation, consultation, and treatment decisions and ultimately improves resource utilization and reduces missed diagnoses.",
          "authors": [
            "Elliot Tissot van Patot",
            "Danielle Roy",
            "Elger Baraku"
          ],
          "year": "2025",
          "journal": "Academic emergency medicine : official journal of the Society for Academic Emergency Medicine",
          "doi": "10.1111/acem.70017",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40070159/"
        },
        {
          "pmid": "37383705",
          "title": "Emergency Presentations for Dizziness-Radiological Findings, Final Diagnoses, and Mortality.",
          "abstract": "Dizziness is a frequent presentation in patients presenting to emergency departments (EDs), often triggering extensive work-up, including neuroimaging. Therefore, gathering knowledge on final diagnoses and outcomes is important. We aimed to describe the incidence of dizziness as primary or secondary complaint, to list final diagnoses, and to determine the use and yield of neuroimaging and outcomes in these patients. Secondary analysis of two observational cohort studies, including all patients presenting to the ED of the University Hospital of Basel from 30th January 2017-19th February 2017 and from 18th March 2019-20th May 2019. Baseline demographics, Emergency Severity Index (ESI), hospitalization, admission to Intensive Care Units (ICUs), and mortality were extracted from the electronic health record database. At presentation, patients underwent a structured interview about their symptoms, defining their primary and secondary complaints. Neuroimaging results were obtained from the picture archiving and communication system (PACS). Patients were categorized into three non-overlapping groups: dizziness as primary complaint, dizziness as secondary complaint, and absence of dizziness. Of 10076 presentations, 232 (2.3%) indicated dizziness as their primary and 984 (9.8%) as their secondary complaint. In dizziness as primary complaint, the three (out of 73 main conditions defined) main diagnoses were nonspecific dizziness (47, 20.3%), dysfunction of the peripheral vestibular system (37, 15.9%), as well as somatization, depression, and anxiety (20, 8.6%). 104 of 232 patients (44.8%) underwent neuroimaging, with relevant findings in 5 (4.8%). In dizziness as primary complaint 30-day mortality was 0%. Work-up for dizziness in emergency presentations has to consider a broad differential diagnosis, but due to the low yield, it should include neuroimaging only in few and selected cases, particularly with additional neurological abnormalities. Presentation with primary dizziness carries a generally favorable prognosis lacking short-term mortality. .",
          "authors": [
            "Jeannette-Marie Busch",
            "Isabelle Arnold",
            "Julia Karakoumis"
          ],
          "year": "2023",
          "journal": "International journal of clinical practice",
          "doi": "10.1155/2023/7450009",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37383705/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "hy controls. common heds complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastroint"
            },
            {
              "percentage": 79.0,
              "context": "tatic cerebral blood flow velocity was reduced in 79% of heds and correlated with orthostatic dizziness. th"
            },
            {
              "percentage": 90.0,
              "context": "espread but mild autonomic failure was present in 90% of heds patients on autonomic testing. small fiber ne"
            }
          ]
        },
        {
          "pmid": "40070159",
          "title": "Validation of the Sudbury Vertigo Risk Score to risk stratify for a serious cause of vertigo.",
          "prevalence_mentions": [
            {
              "percentage": 3.5,
              "context": "epartment (ed) for dizziness, accounting for over 3.5% of all ed visits. of these patients, only 2%-5% recei"
            },
            {
              "percentage": 96.0,
              "context": "dizziness patients undergo a ct scan of the head, 96% of which are negative. despite extensive investigatio"
            }
          ]
        },
        {
          "pmid": "37383705",
          "title": "Emergency Presentations for Dizziness-Radiological Findings, Final Diagnoses, and Mortality.",
          "prevalence_mentions": [
            {
              "percentage": 2.3,
              "context": "bsence of dizziness. of 10076 presentations, 232 (2.3%) indicated dizziness as their primary and 984 (9."
            },
            {
              "percentage": 9.8,
              "context": "3%) indicated dizziness as their primary and 984 (9.8%) as their secondary complaint. in dizziness as pr"
            },
            {
              "percentage": 20.3,
              "context": "d) main diagnoses were nonspecific dizziness (47, 20.3%), dysfunction of the peripheral vestibular system"
            },
            {
              "percentage": 4.8,
              "context": "erwent neuroimaging, with relevant findings in 5 (4.8%). in dizziness as primary complaint 30-day mortal"
            },
            {
              "percentage": 0.0,
              "context": "zziness as primary complaint 30-day mortality was 0%. work-up for dizziness in emergency presentations"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "nerve pain",
    "evidence_tier": 4,
    "tier_label": "‚ö†Ô∏è Emerging Pattern",
    "surprise_score": 0.015,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 1,
      "papers": [
        {
          "pmid": "40322588",
          "title": "High Prevalence of Small-Fiber Neuropathy in Patients with Tarlov Cysts: Toward a More Comprehensive Clinical Understanding.",
          "abstract": "To explore the prevalence of small-fiber neuropathy (SFN) and the clinical characteristics of patients with Tarlov cysts (PTCs), focusing on symptoms related to SFN and increased cerebrospinal pressure. In this retrospective study, 126 surveys assessing symptoms in women (30-69 years) with Tarlov cysts (TCs) ‚â• 7 mm seeking treatment for chronic back, pelvic or leg pain and skin biopsy results from 75 patients assessing intraepidermal nerve fiber density (IENFD) were reviewed. IENFD < 5th percentile was documented in 80% of PTCs according to the normative reference data of Collongues et al and 72% according to the worldwide dataset of Lauria et al Questionnaires revealed high incidences of neuropathic pain (80%), allodynia (76%), pain while sitting (93%), anal sphincter (11%) and urinary sphincter (66%) problems, persistent genital arousal (27%), and restless legs (54%). Autonomic dysfunctions included early satiety (41%), bladder (93%) and bowel (88%) dysfunction, increased sweating (51%), and Raynaud's phenomenon (45%). Other symptoms potentially associated with increased cerebrospinal fluid pressure (CSFP) were headaches (57%), fatigue (86%), cognitive issues (86%), and pulsatile tinnitus (59%). This study revealed a high prevalence of SFN in PTCs (72-80%). Although the TCs may not cause radicular pain in the corresponding dermatomes directly, individuals with TCs frequently report a range of symptoms that have previously been linked to symptomatic TCs, including bladder, bowel, sphincter, and sexual symptoms, as well as local pain. Additionally, seemingly unrelated symptoms, such as headaches, fatigue, cognitive difficulties, neuropathic pain localized in other parts of the body, and autonomic dysfunctions, are commonly reported. These symptoms may be associated with elevated CSFP within the nerve root sheath. Elevated pulsatile CSFP underlies the formation of TCs at the dorsal root ganglion and may gradually contribute to small-fiber dysfunction by irritating, compressing and damaging small nerve fibers within the dorsal root ganglion. : This study focused on how common small-fiber neuropathy (SFN) is in patients with Tarlov cysts (TCs) and examined their symptoms, especially those linked to SFN and increased spinal fluid pressure. : Researchers reviewed surveys from 126 women (ages 30‚Äì69) with TCs larger than 7 mm who sought treatment for chronic back, pelvic, or leg pain. Skin biopsy results from 75 of these patients were also used to quantify small nerve fibers. : A reduction in nerve fiber count per mm skin, a sign of SFN, was found in 72‚Äì80% of patients. Common symptoms included nerve pain (80%), sensitivity to touch (76%), pain while sitting (93%), bladder problems (93%), bowel issues (88%), genital arousal (27%), and restless legs (54%). Many reported headaches (57%), fatigue (86%), memory difficulties (86%), and pulsating ear noise (59%). Other symptoms included autonomic dysfunctions (problems with the body‚Äôs automatic functions), such as sweating problems (51%), and circulation issues like Raynaud‚Äôs phenomenon (45%). : Most patients with TCs show signs of SFN and report various symptoms, including bladder, bowel, and sexual issues, as well as widespread nerve pain and other problems like fatigue and cognitive issues. These symptoms may be caused by increased spinal fluid pressure, which stretches the nerve coverings to form Tarlov cysts and also damages small nerves in the spinal canal. Over time, this pressure could lead to SFN.",
          "authors": [
            "Mieke Hulens",
            "Peter Zajonc",
            "Frans Bruyninckx"
          ],
          "year": "2025",
          "journal": "Journal of pain research",
          "doi": "10.2147/JPR.S513705",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40322588/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40322588",
          "title": "High Prevalence of Small-Fiber Neuropathy in Patients with Tarlov Cysts: Toward a More Comprehensive Clinical Understanding.",
          "prevalence_mentions": [
            {
              "percentage": 80.0,
              "context": "count per mm skin, a sign of sfn, was found in 72‚Äì80% of patients. common symptoms included nerve pain (80%), sensi"
            },
            {
              "percentage": 80.0,
              "context": "of patients. common symptoms included nerve pain (80%), sensitivity to touch (76%), pain while sitting"
            },
            {
              "percentage": 76.0,
              "context": "included nerve pain (80%), sensitivity to touch (76%), pain while sitting (93%), bladder problems (93%"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "lower back pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.014,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 9,
      "frequency": 0.027237354085603113,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "35141647",
          "title": "Sacroiliac joint fusion in patients with Ehlers Danlos Syndrome: A case series.",
          "abstract": "Sacroiliac joint dysfunction (SJD) is a known cause of lower back pain. SJD might be due to hypermobility in the Sacroiliac joint (SIJ) in patients with Ehlers Danlos Syndrome (EDS). Stabilization of the SIJ can be a highly successful treatment for lower back pain. No previous literature about EDS and SIJ fusion is available. The purpose of this study was to assess our mid-term results of SIJ fusion surgery in EDS patients suffering from SIJ dysfunction. A case series of patients who underwent SIJ fusion for SIJ dysfunction due to EDS between January 2012 and December 2018 were analyzed in retrospect. Patients underwent surgery and the SIJ was stabilized with triangular implants bridging the joint. Pain and functional outcomes were assessed in nine agree/disagree questions and a satisfaction performance scale. Clinical data has been extracted from the patient files and in addition, we reassessed the position of the implants on the CT scans. A total of 16 patients with EDS completed the questionnaire and were available for analysis. The mean satisfaction score is 78.1 out of 100 and seven patients reported a 100% satisfaction score. SIJ fusion is a safe and useful procedure to reduce pain and function levels in EDS patients with lower back pain due to SIJ dysfunction.",
          "authors": [
            "Iris Beijk",
            "Rob Knoef",
            "Arie van Vugt"
          ],
          "year": "2021",
          "journal": "North American Spine Society journal",
          "doi": "10.1016/j.xnsj.2021.100082",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35141647/"
        },
        {
          "pmid": "39087018",
          "title": "Co-occurrence of tethered cord syndrome and cervical spine instability in hypermobile Ehlers-Danlos syndrome.",
          "abstract": "The Ehlers-Danlos Syndromes (EDS) represent a group of hereditary connective tissue disorders, with the hypermobile subtype (hEDS) being the most prevalent. hEDS manifests with a diverse array of clinical symptoms and associated comorbidities spanning the musculoskeletal, neurological, gastrointestinal, cardiovascular, and immunological systems. hEDS patients may experience spinal neurological complications, including cervico-medullary symptoms arising from cranio-cervical and/or cervical instability/hypermobility, as well as tethered cord syndrome (TCS). TCS is often radiographically occult in nature, not always detectable on standard imaging and presents with lower back pain, balance issues, weakness in the lower extremities, sensory loss, and bowel or bladder dysfunction. Cervical instability due to ligament laxity can lead to headaches, vertigo, tinnitus, vision changes, syncope, radiculopathy, pain, and dysphagia. TCS and cervical instability not only share clinical features but can also co-occur in hEDS patients, posing challenges in diagnostics and clinical management. We present a review of the literature and a case study of a 20-year-old female with hEDS, who underwent surgical interventions for these conditions, highlighting the challenges in diagnosing and managing these complexities and underscoring the importance of tailored treatment strategies to improve patient outcomes.",
          "authors": [
            "Cortney Gensemer",
            "Victoria Daylor",
            "Jared Nix"
          ],
          "year": "2024",
          "journal": "Frontiers in neurology",
          "doi": "10.3389/fneur.2024.1441866",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39087018/"
        },
        {
          "pmid": "33078159",
          "title": "Rupture of a Median Sacral Artery Aneurysm in a Patient with Vascular Ehlers Danlos Syndrome.",
          "abstract": "Vascular Ehlers Danlos syndrome is a rare connective tissue disease that is associated with various arterial complications. A 25 year old man with vascular Ehlers Danlos syndrome presented with acute lower back pain as a result of a ruptured aneurysm of the median sacral artery (MSA). Prior medical history included several vascular events resulting in a right iliac occlusion. The unusual location of aneurysmal disease of the MSA might be explained by extensive collateral flow recruitment due to this occlusion. Previous vascular events inducing collateral recruitment might justify a more frequent follow up in patients with connective tissue disorders.",
          "authors": [
            "Merel J Verhagen",
            "Rutger W van der Meer",
            "Carla S P van Rijswijk"
          ],
          "year": "2020",
          "journal": "EJVES vascular forum",
          "doi": "10.1016/j.ejvssr.2019.12.002",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33078159/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40998571",
          "title": "Emergency physicians' perspectives on integrating physiotherapists into emergency departments: a national survey from France.",
          "prevalence_mentions": [
            {
              "percentage": 74.5,
              "context": "elegation included suspected ankle sprains n=313 (74.5%), knee sprains n=277 (66.0%) and lower back pain"
            },
            {
              "percentage": 66.0,
              "context": "ankle sprains n=313 (74.5%), knee sprains n=277 (66.0%) and lower back pain n=271 (64.5%). compared with"
            },
            {
              "percentage": 64.5,
              "context": "sprains n=277 (66.0%) and lower back pain n=271 (64.5%). compared with junior colleagues, senior physici"
            }
          ]
        },
        {
          "pmid": "33963027",
          "title": "Chronic Low Back Pain Occurring in Association With Hypermobility Spectrum Disorder and Ehlers-Danlos Syndrome.",
          "prevalence_mentions": [
            {
              "percentage": 50.0,
              "context": "ile eds population have been reported to be up to 50%. when hypermobility and chronic lumbar back pain"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "neck pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.012,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 8,
      "frequency": 0.023346303501945526,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "38163828",
          "title": "Craniocervical instability in patients with Ehlers-Danlos syndromes: outcomes analysis following occipito-cervical fusion.",
          "abstract": "Craniocervical instability (CCI) is increasingly recognized in hereditary disorders of connective tissue and in some patients following suboccipital decompression for Chiari malformation (CMI) or low-lying cerebellar tonsils (LLCT). CCI is characterized by severe headache and neck pain, cervical medullary syndrome, lower cranial nerve deficits, myelopathy, and radiological metrics, for which occipital cervical fusion (OCF) has been advocated. We conducted a retrospective analysis of patients with CCI and Ehlers-Danlos syndrome (EDS) to determine whether the surgical outcomes supported the criteria by which patients were selected for OCF. Fifty-three consecutive subjects diagnosed with EDS, who presented with severe head and neck pain, lower cranial nerve deficits, cervical medullary syndrome, myelopathy, and radiologic findings of CCI, underwent open reduction, stabilization, and OCF. Thirty-two of these patients underwent suboccipital decompression for obstruction of cerebral spinal fluid flow. Questionnaire data and clinical findings were abstracted by a research nurse. Follow-up questionnaires were administered at 5-28¬†months (mean 15.1). The study group demonstrated significant improvement in headache and neck pain (p‚Äâ<‚Äâ0.001), decreased use of pain medication (p‚Äâ<‚Äâ0.0001), and improved Karnofsky Performance Status score (p‚Äâ<‚Äâ0.001). Statistically significant improvement was also demonstrated for nausea, syncope (p‚Äâ<‚Äâ0.001), speech difficulties, concentration, vertigo, dizziness, numbness, arm weakness, and fatigue (p‚Äâ=‚Äâ0.001). The mental fatigue score and orthostatic grading score were improved (p‚Äâ<‚Äâ0.01). There was no difference in pain improvement between patients with CMI/LLCT and those without. This outcomes analysis of patients with disabling CCI in the setting of EDS demonstrated significant benefits of OCF. The results support the reasonableness of the selection criteria for OCF. We advocate for a multi-center, prospective clinical trial of OCF in this population.",
          "authors": [
            "Fraser C Henderson",
            "Jane R Schubart",
            "Malini V Narayanan"
          ],
          "year": "2024",
          "journal": "Neurosurgical review",
          "doi": "10.1007/s10143-023-02249-0",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38163828/"
        },
        {
          "pmid": "32211867",
          "title": "Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department.",
          "abstract": "Opioid prescriptions for treatment of pain in emergency departments (EDs) are associated with long-term opioid use. The temporal pattern of opioid prescribing in the context of the opioid epidemic remains unknown. To examine the temporal pattern of opioid prescribing within an ED for varying pain conditions between 2009 and 2018. A population-based, cross-sectional study was conducted at the ED of an urban academic medical center. All patients treated within that ED between January 1, 2009, and December 31, 2018, were included. The proportion of patients prescribed an opioid for treatment of pain in the ED temporally by condition, condition type, patient demographics, and physician prescriber. Between 2009 and 2018, 556‚ÄØ176 patient encounters took place in the ED, with 70‚ÄØ218 unique opioid prescriptions ordered. A total of 316 632 patients (55.9%) were female, 45 070 (42.6%) were of white race, and 43 412 (40.6%) were privately insured; the median age group was 41 to 45 years. Yearly opioid prescriptions decreased by 66.3% (from 16.3 to 5.5 opioids per 100 encounters) between 2013 and 2018, with a yearly adjusted odds ratio (aOR) of 0.808 (95% CI, 0.802-0.814) compared with the prior year. In patients with musculoskeletal pain (back, joint, limb, and neck pain), opioid prescribing decreased by 71.1% (from 36.7 to 10.6 opioids per 100 encounters between 2013 and 2018; aOR,‚Äâ0.758; 95% CI, 0.744-0.773). In patients with musculoskeletal trauma (fracture, sprain, contusion, and injury), opioid prescribing decreased by 58.0% (from 34.2 to 14.8 opioids per 100 encounters; aOR, 0.811; 95% CI, 0.797-0.824). In patients with nonmusculoskeletal pain (abdominal pain, kidney stone, respiratory distress, and pharyngitis) opioid prescribing decreased by 53.7% (from 20.1 to 9.3 opioids per 100 encounters; aOR, 0.850; 95% CI, 0.834-0.868). Between 2009 and 2018, patients who were black (aOR, 0.760; 95% CI, 0.741-0.779) and those who were Asian (aOR, 0.714; 95% CI, 0.665-0.764) had the lowest odds of receiving an opioid compared with other racial/ethnic groups. There was a substantial temporal decrease in the number of opioid prescriptions within this ED during the study period. This decrease was associated with substantial relative reductions in opioid prescribing for treatment of musculoskeletal pain compared with fractures and kidney stones.",
          "authors": [
            "Ben C Smith",
            "Andrew D Vigotsky",
            "A Vania Apkarian"
          ],
          "year": "2020",
          "journal": "JAMA network open",
          "doi": "10.1001/jamanetworkopen.2020.0802",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32211867/"
        },
        {
          "pmid": "40998571",
          "title": "Emergency physicians' perspectives on integrating physiotherapists into emergency departments: a national survey from France.",
          "abstract": "Emergency departments (EDs) worldwide are facing increasing patient volumes and thus crowding, prolonged waiting times and rising healthcare costs. In France, ED visits rose from 8.5 to 16‚Äâmillion between 2014 and 2024. To address these challenges, several countries (including Australia, the UK and Canada) have integrated physiotherapists into EDs in advanced practice roles-primarily for musculoskeletal (MSK) conditions. In contrast, this type of integration is rare in the French healthcare system. The objective of the present study was to assess the attitudes of French emergency physicians to the incorporation of physiotherapists into ED teams. A nationwide, cross-sectional survey of emergency physicians practising in France was conducted between 22 November 2023 and 15 February 2024. The study questionnaire assessed the physicians' willingness to collaborate with physiotherapists, the perceived benefits of collaboration and views on task delegation. Descriptive statistics and œá¬≤ tests were used to analyse the data. Of the 420 respondents, 333 (79.3%) expressed willingness to collaborate with physiotherapists in EDs. The most commonly cited benefits were improved quality of care n=321 (76.4%), greater patient satisfaction n=318 (75.7%), a lower physician workload n=276 (67.5%) and enhanced ED efficiency n=211 (50.2%). The conditions most frequently considered for delegation included suspected ankle sprains n=313 (74.5%), knee sprains n=277 (66.0%) and lower back pain n=271 (64.5%). Compared with junior colleagues, senior physicians with five or more years of experience were significantly more supportive of delegating cases of neck pain (n=110, 41.7%, p=0.017). French emergency physicians are generally supportive of integrating physiotherapists into EDs, especially for the management of non-urgent MSK conditions. The physicians see physiotherapists as capable of providing on-site care and patient education, potentially improving patient flow and alleviating pressures in overcrowded EDs. These findings offer valuable insights for countries in which the integration of physiotherapy into emergency care is still emerging.",
          "authors": [
            "Justine Malcuit",
            "Emilie Lesieur",
            "Daniel Aiham Ghazali"
          ],
          "year": "2025",
          "journal": "Emergency medicine journal : EMJ",
          "doi": "10.1136/emermed-2024-214746",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40998571/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "32211867",
          "title": "Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department.",
          "prevalence_mentions": [
            {
              "percentage": 71.1,
              "context": ", and neck pain), opioid prescribing decreased by 71.1% (from 36.7 to 10.6 opioids per 100 encounters betw"
            }
          ]
        },
        {
          "pmid": "40998571",
          "title": "Emergency physicians' perspectives on integrating physiotherapists into emergency departments: a national survey from France.",
          "prevalence_mentions": [
            {
              "percentage": 41.7,
              "context": "pportive of delegating cases of neck pain (n=110, 41.7%, p=0.017). french emergency physicians are genera"
            }
          ]
        },
        {
          "pmid": "36082197",
          "title": "Cervical Artery Dissections: Etiopathogenesis and Management.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "ns related to cead are headache and neck pain (65-95%), tia/ischemic stroke (>50%), and partial horner'"
            },
            {
              "percentage": 50.0,
              "context": "che and neck pain (65-95%), tia/ischemic stroke (>50%), and partial horner's syndrome (25%). the prevai"
            }
          ]
        },
        {
          "pmid": "26802501",
          "title": "Interpreting the National Hospital Ambulatory Medical Care Survey: United States Emergency Department Opioid Prescribing, 2006-2010.",
          "prevalence_mentions": [
            {
              "percentage": 62.1,
              "context": "f opioids prescriptions included nephrolithiasis (62.1%), neck pain (51.6%), and dental/jaw pain (49.7%)."
            },
            {
              "percentage": 51.6,
              "context": "ions included nephrolithiasis (62.1%), neck pain (51.6%), and dental/jaw pain (49.7%). a pain-related dis"
            },
            {
              "percentage": 49.7,
              "context": "(62.1%), neck pain (51.6%), and dental/jaw pain (49.7%). a pain-related discharge diagnosis, non-hispani"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "wrist pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.012,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 5,
      "papers": [
        {
          "pmid": "35399421",
          "title": "Racial Disparity in Pediatric Radiography for Forearm Fractures.",
          "abstract": "The most common pediatric fractures involve the upper extremity. But there is limited study on racial disparity in diagnostic radiography for pediatric fractures. The literature has described the diagnostic accuracy of alternative diagnostic modalities with promising evidence of its ability to mitigate health inequity in primary care. Our objective was to understand if racial disparity exists in radiography for pediatric fractures. In this four-year retrospective cohort study, we analyzed rates of radiographic imaging and abnormal radiograph detection in 4280 pediatric patients (ages 3-18 years) who presented with chief complaints of arm or wrist pain and trauma-related International Classification of Diseases 10th Revision (ICD-10) codes. We compared White children to all other races and stratified by emergency departments (ED) vs all other primary care ambulatory service lines.¬† Results: Non-White patients had lower imaging rate differences and lower odds receiving imaging in both ambulatory settings (0.65915, P = 0.0162; -5.4%, P = 0.0143) and in EDs (0.7732, P = 0.0369; -4.7%, P = 0.0368). Additionally, non-Whites in the ED had lower rates and lower odds of abnormal radiographs (-7.3%, P = 0.0084; 0.6794, P = 0.0089).¬† Conclusion: Non-White patients seen in emergency and ambulatory settings had lower imaging rates for traumatic arm and wrist pain compared to White patients, indicating a healthcare disparity in pediatric imaging. Higher-level studies investigating the effect of social determinants of health, more detailed patient data, and provider bias on facture care equity are needed to understand underlying reasons for observed differences.",
          "authors": [
            "Derek J Baughman",
            "Taofeek Akinpelu",
            "Abdul Waheed"
          ],
          "year": "2022",
          "journal": "Cureus",
          "doi": "10.7759/cureus.22850",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35399421/"
        },
        {
          "pmid": "22045539",
          "title": "Is hypermobility syndrome (HMS) a contributing factor for chronic unspecific wrist pain in a musician? If so, how is it evaluated and managed?",
          "abstract": "The musician complaining of chronic pain commonly presents with subtle and complicated findings. Joint hypermobility is common in these individuals. The diagnosis of joint hypermobility syndrome (HMS) does not merely involve joint laxity, but connective tissue impairment throughout the body as well as perhaps involving the neurological system. As the aging process gradually reduces joint laxity, chronic pain and various impairments may linger. This report investigates HMS as it relates to a case study involving a musician suffering with chronic joint pain and HMS. Literature review and case description. HMS involves more than just joint laxity and may be the cause of various chronic pain dysfunctions. The prognosis for recovery from HMS is poor, but the education and psychological aspect is extremely beneficial to the patient's health and well-being. This case report identified a musician with CUWP and HMS. Joint hypermobility syndrome does not merely involve joint laxity, but involves connective tissue impairment throughout the body as well as perhaps involving the body's neurological system. Joint hypermobility is common in musicians.",
          "authors": [
            "Nicholas F Quarrier"
          ],
          "year": "2011",
          "journal": "Work (Reading, Mass.)",
          "doi": "10.3233/WOR-2011-1239",
          "url": "https://pubmed.ncbi.nlm.nih.gov/22045539/"
        },
        {
          "pmid": "40672794",
          "title": "Soft Tissue Stabilization of Midcarpal Instability in Ehlers-Danlos Patients Using a Cadaveric Tendon Graft.",
          "abstract": "Ehlers-Danlos syndrome (EDS) is a group of hereditary disorders that affects collagen synthesis. In the wrist, pain and midcarpal laxity may affect up to 70% of EDS patients. The mainstay treatment of midcarpal instability in patients with ligamentous injury but not EDS includes orthotics, physiotherapy, and activity modification. These methods of conservative treatment may be unsuccessful in controlling instability in the longer term. Using autologous tendon for reconstructing midcarpal instability in patients with EDS carries the risk of loosening over time due to intrinsic abnormalities in collagen metabolism. In this article, we present a novel surgical technique using a cadaveric tendon graft to stabilize bilateral midcarpal instability in EDS patients. A triangular ligament reconstruction from the base of the third metacarpal to the lunate and triquetrum was designed to treat midcarpal instability.",
          "authors": [
            "Mohammed Muneer",
            "Fadi Bouri",
            "Kjell Van Royen"
          ],
          "year": "2025",
          "journal": "Plastic and reconstructive surgery. Global open",
          "doi": "10.1097/GOX.0000000000006963",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40672794/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "35399421",
          "title": "Racial Disparity in Pediatric Radiography for Forearm Fractures.",
          "prevalence_mentions": [
            {
              "percentage": 5.4,
              "context": "n both ambulatory settings (0.65915, p = 0.0162; -5.4%, p = 0.0143) and in eds (0.7732, p = 0.0369; -4.7"
            },
            {
              "percentage": 4.7,
              "context": ".4%, p = 0.0143) and in eds (0.7732, p = 0.0369; -4.7%, p = 0.0368). additionally, non-whites in the ed"
            }
          ]
        },
        {
          "pmid": "40672794",
          "title": "Soft Tissue Stabilization of Midcarpal Instability in Ehlers-Danlos Patients Using a Cadaveric Tendon Graft.",
          "prevalence_mentions": [
            {
              "percentage": 70.0,
              "context": "wrist, pain and midcarpal laxity may affect up to 70% of eds patients. the mainstay treatment of midcarpal"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "foot pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.012,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 4,
      "papers": [
        {
          "pmid": "32093191",
          "title": "Custom-Made Foot Orthoses Reduce Pain and Fatigue in Patients with Ehlers-Danlos Syndrome. A Pilot Study.",
          "abstract": "Pain and fatigue are major clinical manifestations in patients with Ehlers-Danlos Syndrome (EDS). The aim of this study is to measure change of the effects of custom-made foot orthotics on some manifestations related to EDS, such as foot pain, foot functionality, fatigue, and quality of life. Thirty-six patients with EDS wore foot orthoses for three months. Foot pain, foot-related disability, foot functionality, fatigue, and quality of life were measured using the 11-point Numeric Rating Scale, the Manchester Foot Pain and Disability Index, the Foot Function Index, the Fatigue Severity Score, and the 12-Item Short Form Health Survey questionnaires, respectively, at the beginning and after 3 months. Participants demonstrated significantly improved foot pain ( The use of custom-made foot orthoses help in the management of the symptoms by participants. This study could contribute to the foot specialists being considered as an additional member in multidisciplinary teams that are trying to develop an approach for patients with EDS.",
          "authors": [
            "Mar√≠a Reina-Bueno",
            "Carmen V√°zquez-Bautista",
            "Inmaculada C Palomo-Toucedo"
          ],
          "year": "2020",
          "journal": "International journal of environmental research and public health",
          "doi": "10.3390/ijerph17041359",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32093191/"
        },
        {
          "pmid": "37834928",
          "title": "Foot Pain and Disability in Women with Rheumatoid Arthritis, Ehlers-Danlos Syndrome and Systemic Lupus Erythematosus: Relationship with Quality of Life.",
          "abstract": "The aim of this work was to investigate the relationship foot pain and foot disability have with HRQoL in groups of women with RA, SLE and EDS, in comparison with a control group. A cross-sectional study was carried out with females with one of these conditions and a control group. The SF-12 questionnaire was used to collect data about quality of life. The type of foot was classified according to the footprint and the foot posture index. A total of 156 patients and 47 controls participated in the study (",
          "authors": [
            "Inmaculada C Palomo-Toucedo",
            "Gabriel Dom√≠nguez-Maldonado",
            "Mar√≠a Reina-Bueno"
          ],
          "year": "2023",
          "journal": "Journal of clinical medicine",
          "doi": "10.3390/jcm12196284",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37834928/"
        },
        {
          "pmid": "31255365",
          "title": "Podiatry alterations in Ehlers-Danlos syndrome.",
          "abstract": "This paper aims to describe the type of foot and most frequent podiatric alterations, as well as the level of pain, disability, fatigue and alteration of quality of life in patients with Ehlers-Danlos syndrome (EDS). Thirty-eight individuals with hypermobile or classic EDS participated. The percentage of pain in the foot and deformities was recorded, and several questionnaires were administered. The type of foot was classified according to the footprint and the Foot Posture Index. There was a high degree of pain, disability, intensity of fatigue and low quality of life in these patients. According to the footprint, 20% presented flat feet, 47% normal feet and 33% cavus feet. The participants in this study had a high percentage of foot problems related to high levels of pain and limited functionality in the feet. The quality of life of these patients appeared diminished. Foot types were observed according to the footprint and deformities similar to those of the general population.",
          "authors": [
            "Inmaculada C Palomo-Toucedo",
            "Carmen V√°zquez-Bautista",
            "Pedro V Munuera-Mart√≠nez"
          ],
          "year": "2020",
          "journal": "Medicina clinica",
          "doi": "10.1016/j.medcli.2019.05.006",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31255365/"
        }
      ],
      "prevalence_data": []
    }
  },
  {
    "symptom": "hypermobile",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.011,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 7,
      "frequency": 0.019455252918287938,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 9,
      "papers": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive evaluations of a larger sample of hEDS patients are lacking. The objective of this study was to describe cerebrovascular, autonomic, and neuropathic features of hEDS. This retrospective case-control study was conducted at Brigham and Women's Faulkner Hospital between 2016-2023. Data from hEDS patients who completed autonomic testing and skin biopsies were analyzed. Outcome measures include validated surveys (Survey of Autonomic Functions, Neuropathy Total Symptom Score-6 (SAS)) and autonomic function testing (Valsalva maneuver, deep breathing, head-up tilt and sudomotor), cerebrovascular (cerebral blood flow velocity (CBFv) in the middle cerebral artery), respiratory (capnography), and neuropathic (skin biopsies for assessment of small fiber neuropathy) testing and inflammatory/ autoimmune markers. Total 270 hEDS patients were analyzed and compared to 29 healthy controls. Common hEDS complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastrointestinal, and pain. Orthostatic cerebral blood flow velocity was reduced in 79% of hEDS and correlated with orthostatic dizziness. The head-up tilt test revealed postural tachycardia syndrome (prevalence 33%), hypocapnic cerebral hypoperfusion (22%), orthostatic cerebral hypoperfusion syndrome (18%), and neurogenic orthostatic hypotension (9%). Widespread but mild autonomic failure was present in 90% of hEDS patients on autonomic testing. Small fiber neuropathy using structural criteria was detected in 64%, and using combined structural and functional criteria in 82%. This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread but mild autonomic failure in hEDS.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2025",
          "journal": "American journal of medicine open",
          "doi": "10.1016/j.ajmo.2025.100111",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40843452/"
        },
        {
          "pmid": "32629534",
          "title": "Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.",
          "abstract": "The Ehlers-Danlos syndromes (EDS) are a group of heritable, connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility. There is phenotypic and genetic variation among the 13 subtypes. The initial genetic findings on EDS were related to alterations in fibrillar collagen, but the elucidation of the molecular basis of many of the subtypes revealed several genes not involved in collagen biosynthesis or structure. However, the genetic basis of the hypermobile type of EDS (hEDS) is still unknown. hEDS is the most common type of EDS and involves generalized joint hypermobility, musculoskeletal manifestations, and mild skin involvement along with the presence of several comorbid conditions. Variability in the spectrum and severity of symptoms and progression of patient phenotype likely depend on age, gender, lifestyle, and expression domains of the EDS genes during development and postnatal life. In this review, we summarize the current molecular, genetic, epidemiologic, and pathogenetic findings related to EDS with a focus on the hypermobile type.",
          "authors": [
            "Cortney Gensemer",
            "Randall Burks",
            "Steven Kautz"
          ],
          "year": "2021",
          "journal": "Developmental dynamics : an official publication of the American Association of Anatomists",
          "doi": "10.1002/dvdy.220",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32629534/"
        },
        {
          "pmid": "32732924",
          "title": "The Ehlers-Danlos syndromes.",
          "abstract": "The Ehlers-Danlos syndromes (EDS) are a heterogeneous group of hereditary disorders of connective tissue, with common features including joint hypermobility, soft and hyperextensible skin, abnormal wound healing and easy bruising. Fourteen different types of EDS are recognized, of which the molecular cause is known for 13 types. These types are caused by variants in 20 different genes, the majority of which encode the fibrillar collagen types I, III and V, modifying or processing enzymes for those proteins, and enzymes that can modify glycosaminoglycan chains of proteoglycans. For the hypermobile type of EDS, the molecular underpinnings remain unknown. As connective tissue is ubiquitously distributed throughout the body, manifestations of the different types of EDS are present, to varying degrees, in virtually every organ system. This can make these disorders particularly challenging to diagnose and manage. Management consists of a care team responsible for surveillance of major and organ-specific complications (for example, arterial aneurysm and dissection), integrated physical medicine and rehabilitation. No specific medical or genetic therapies are available for any type of EDS.",
          "authors": [
            "Fransiska Malfait",
            "Marco Castori",
            "Clair A Francomano"
          ],
          "year": "2020",
          "journal": "Nature reviews. Disease primers",
          "doi": "10.1038/s41572-020-0194-9",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32732924/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "hy controls. common heds complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastroint"
            },
            {
              "percentage": 79.0,
              "context": "tatic cerebral blood flow velocity was reduced in 79% of heds and correlated with orthostatic dizziness. th"
            },
            {
              "percentage": 90.0,
              "context": "espread but mild autonomic failure was present in 90% of heds patients on autonomic testing. small fiber ne"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "POTS",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.01,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 7,
      "frequency": 0.019455252918287938,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive evaluations of a larger sample of hEDS patients are lacking. The objective of this study was to describe cerebrovascular, autonomic, and neuropathic features of hEDS. This retrospective case-control study was conducted at Brigham and Women's Faulkner Hospital between 2016-2023. Data from hEDS patients who completed autonomic testing and skin biopsies were analyzed. Outcome measures include validated surveys (Survey of Autonomic Functions, Neuropathy Total Symptom Score-6 (SAS)) and autonomic function testing (Valsalva maneuver, deep breathing, head-up tilt and sudomotor), cerebrovascular (cerebral blood flow velocity (CBFv) in the middle cerebral artery), respiratory (capnography), and neuropathic (skin biopsies for assessment of small fiber neuropathy) testing and inflammatory/ autoimmune markers. Total 270 hEDS patients were analyzed and compared to 29 healthy controls. Common hEDS complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastrointestinal, and pain. Orthostatic cerebral blood flow velocity was reduced in 79% of hEDS and correlated with orthostatic dizziness. The head-up tilt test revealed postural tachycardia syndrome (prevalence 33%), hypocapnic cerebral hypoperfusion (22%), orthostatic cerebral hypoperfusion syndrome (18%), and neurogenic orthostatic hypotension (9%). Widespread but mild autonomic failure was present in 90% of hEDS patients on autonomic testing. Small fiber neuropathy using structural criteria was detected in 64%, and using combined structural and functional criteria in 82%. This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread but mild autonomic failure in hEDS.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2025",
          "journal": "American journal of medicine open",
          "doi": "10.1016/j.ajmo.2025.100111",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40843452/"
        },
        {
          "pmid": "39692313",
          "title": "Mast Cell Activation Syndrome and the Triad of MCAS, POTS, and Hypermobile EDS.",
          "abstract": null,
          "authors": [
            "Leonard B Weinstock"
          ],
          "year": "2024",
          "journal": "The American journal of gastroenterology",
          "doi": "10.14309/ajg.0000000000003201",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39692313/"
        },
        {
          "pmid": "31267471",
          "title": "The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).",
          "abstract": "In recent years, an association between hypermobile Ehlers-Danlos syndrome (hEDS), mast cell activation syndrome (MCAS), and postural orthostatic tachycardia syndrome (POTS) has garnered attention and patients are increasingly presenting with this triad. However, a real relationship between these entities is unclear due to a lack of scientific validity. We conducted an extensive review of the literature using two different search strategies. A narrower strategy included 88 searches of various combinations of terms for each of the three conditions, yielding 19 unique papers. A broader search included 136 searches of various combinations of terms but included all forms of EDS and yielded 40 unique papers. Of these, only four and nine papers from the narrower and broader search strategies were original research articles. None of these papers resulted from a combination of the search terms for the three conditions. All three clinical entities are controversial in either existence or pathogenesis. MCAS is a poorly defined clinical entity, and many studies do not adhere to the proposed criteria when establishing the diagnosis. Patients previously diagnosed with EDS hypermobility type may not meet the new, stricter criteria for hEDS but may for a less severe hypermobility spectrum disorder (HSD). The pathophysiology of POTS is still unclear. An evidence-based, common pathophysiologic mechanism between any of the two, much less all three conditions, has yet to be described. Our review of the literature shows that current evidence is lacking on the existence of MCAS or hEDS as separate or significant clinical entities. Studies proposing a relationship between the three clinical entities are either biased or based on outdated criteria. The reason behind the purported association of these entities stems from an overlapping pool of vague, subjective symptoms, which is inadequate evidence to conclude that any such relationship exists.",
          "authors": [
            "Alison Haley Kucharik",
            "Christopher Chang"
          ],
          "year": "2020",
          "journal": "Clinical reviews in allergy & immunology",
          "doi": "10.1007/s12016-019-08755-8",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31267471/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "40843452",
          "title": "Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Features.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "hy controls. common heds complaints (prevalence > 90% ) were orthostatic sudomotor, vasomotor, gastroint"
            },
            {
              "percentage": 79.0,
              "context": "tatic cerebral blood flow velocity was reduced in 79% of heds and correlated with orthostatic dizziness. th"
            },
            {
              "percentage": 90.0,
              "context": "espread but mild autonomic failure was present in 90% of heds patients on autonomic testing. small fiber ne"
            }
          ]
        },
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "chronic fatigue",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.009,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 9,
      "papers": [
        {
          "pmid": "38291116",
          "title": "Mismatch between subjective and objective dysautonomia.",
          "abstract": "Autonomic symptom questionnaires are frequently used to assess dysautonomia. It is unknown whether subjective dysautonomia obtained from autonomic questionnaires correlates with objective dysautonomia measured by quantitative autonomic testing. The objective of our study was to determine correlations between subjective and objective measures of dysautonomia. This was a retrospective cross-sectional study conducted at Brigham and Women's Faulkner Hospital Autonomic Laboratory between 2017 and 2023 evaluating the patients who completed autonomic testing. Analyses included validated autonomic questionnaires [Survey of Autonomic Symptoms (SAS), Composite Autonomic Symptom Score 31 (Compass-31)] and standardized autonomic tests (Valsalva maneuver, deep breathing, sudomotor, and tilt test). The autonomic testing results were graded by a Quantitative scale for grading of cardiovascular reflexes, sudomotor tests and skin biopsies (QASAT), and Composite Autonomic Severity Score (CASS). Autonomic testing, QASAT, CASS, and SAS were obtained in 2627 patients, and Compass-31 in 564 patients. The correlation was strong between subjective instruments (SAS vs. Compass-31, r‚Äâ=‚Äâ0.74, p‚Äâ<‚Äâ0.001) and between objective instruments (QASAT vs. CASS, r‚Äâ=‚Äâ0.81, p‚Äâ<‚Äâ0.001). There were no correlations between SAS and QASAT nor between Compass-31 and CASS. There continued to be no correlations between subjective and objective instruments for selected diagnoses (post-acute sequelae of COVID-19, n‚Äâ=‚Äâ61; postural tachycardia syndrome, 211; peripheral autonomic neuropathy, 463; myalgic encephalomyelitis/chronic fatigue syndrome, 95; preload failure, 120; post-treatment Lyme disease syndrome, 163; hypermobile Ehlers-Danlos syndrome, 213; neurogenic orthostatic hypotension, 86; diabetes type II, 71, mast cell activation syndrome, 172; hereditary alpha tryptasemia, 45). The lack of correlation between subjective and objective instruments highlights the limitations of the commonly used questionnaires with some patients overestimating and some underestimating true autonomic deficit. The diagnosis-independent subjective-objective mismatch further signifies the unmet need for reliable screening surveys. Patients who overestimate the symptom burden may represent a population with idiosyncratic autonomic-like symptomatology, which needs further study. At this time, the use of autonomic questionnaires as a replacement of autonomic testing cannot be recommended.",
          "authors": [
            "Peter Novak",
            "David M Systrom",
            "Sadie P Marciano"
          ],
          "year": "2024",
          "journal": "Scientific reports",
          "doi": "10.1038/s41598-024-52368-x",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38291116/"
        },
        {
          "pmid": "30286454",
          "title": "Chronic Fatigue Syndrome: From Chronic Fatigue to More Specific Syndromes.",
          "abstract": "In the last decade, a group of chronic disorders associated with fatigue (CDAF) emerged as the leading cause of chronic fatigue, chronic pain, and functional impairment, all of which have been often labeled in clinical practice as chronic fatigue syndrome (CFS) or fibromyalgia. While these chronic disorders arise from various pathophysiologic mechanisms, a shared autoimmune or immune-mediated etiology could shift the focus from symptomatic treatment of fatigue and pain to targeted immunomodulatory and biological therapy. A clinical paradigm shift is necessary to reevaluate CFS and fibromyalgia diagnoses and its relationship to the CDAF entities, which would ultimately lead to a change in diagnostic and therapeutic algorithm for patients with chronic fatigue and chronic pain. Rather than uniformly apply the diagnoses of CFS or fibromyalgia to any patient presenting with unexplained chronic fatigue or chronic pain, it may be more beneficial and therapeutically effective to stratify these patients into more specific diagnoses in the CDAF group.",
          "authors": [
            "Svetlana Blitshteyn",
            "Pradeep Chopra"
          ],
          "year": "2018",
          "journal": "European neurology",
          "doi": "10.1159/000493531",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30286454/"
        },
        {
          "pmid": "34454716",
          "title": "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management.",
          "abstract": "Despite myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) affecting millions of people worldwide, many clinicians lack the knowledge to appropriately diagnose or manage ME/CFS. Unfortunately, clinical guidance has been scarce, obsolete, or potentially harmful. Consequently, up to 91% of patients in the United States remain undiagnosed, and those diagnosed often receive inappropriate treatment. These problems are of increasing importance because after acute COVID-19, a significant percentage of people remain ill for many months with an illness similar to ME/CFS. In 2015, the US National Academy of Medicine published new evidence-based clinical diagnostic criteria that have been adopted by the US Centers for Disease Control and Prevention. Furthermore, the United States and other governments as well as major health care organizations have recently withdrawn graded exercise and cognitive-behavioral therapy as the treatment of choice for patients with ME/CFS. Recently, 21 clinicians specializing in ME/CFS convened to discuss best clinical practices for adults affected by ME/CFS. This article summarizes their top recommendations for generalist and specialist health care providers based on recent scientific progress and decades of clinical experience. There are many steps that clinicians can take to improve the health, function, and quality of life of those with ME/CFS, including those in whom ME/CFS develops after COVID-19. Patients with a lingering illness that follows acute COVID-19 who do not fully meet criteria for ME/CFS may also benefit from these approaches.",
          "authors": [
            "Lucinda Bateman",
            "Alison C Bested",
            "Hector F Bonilla"
          ],
          "year": "2021",
          "journal": "Mayo Clinic proceedings",
          "doi": "10.1016/j.mayocp.2021.07.004",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34454716/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39301475",
          "title": "Long COVID and hypermobility spectrum disorders have shared pathophysiology.",
          "prevalence_mentions": [
            {
              "percentage": 90.0,
              "context": "ith hypermobile and classical eds accounting for >90% of all cases. hypermobility has been detected in up t"
            },
            {
              "percentage": 57.0,
              "context": "ases. hypermobility has been detected in up to 30-57% of patients with myalgic encephalomyelitis/chronic fatigue sy"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "shoulder pain",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "30094145",
          "title": "Posterior Glenohumeral Capsular Reconstruction Using an Acellular Dermal Allograft.",
          "abstract": "Posterior shoulder instability is an uncommon and challenging cause of shoulder pain and dysfunction. Surgical management has less reliable results and higher failure rates compared with techniques for anterior shoulder instability. The presence of generalized ligamentous laxity further complicates options for surgical management. If primary capsulolabral repair fails, controversy exists as to the optimal revision procedure. This technical description and video present an arthroscopic technique for reconstruction of the posterior glenohumeral capsule with an acellular dermal allograft to treat posterior instability in a patient with Ehlers-Danlos syndrome and a previously failed posterior capsular plication.",
          "authors": [
            "Jillian Karpyshyn",
            "Erin E Gordey",
            "Catherine M Coady"
          ],
          "year": "2018",
          "journal": "Arthroscopy techniques",
          "doi": "10.1016/j.eats.2018.03.011",
          "url": "https://pubmed.ncbi.nlm.nih.gov/30094145/"
        },
        {
          "pmid": "38090927",
          "title": "The Scapula: The Greater Masquerader of ‚Ä®Shoulder Pathologies.",
          "abstract": "A comprehensive review of scapular pathologies and their effect on shoulder function is necessary to determine the best treatment options. The coordinated motion between the scapulothoracic and glenohumeral joints is essential for shoulder motion and depends on the balanced activity of the periscapular muscles. Disruption in these muscles can cause abnormal scapular motion and compensatory glenohumeral movements, leading to misdiagnosis or delayed diagnosis. Scapular pathologies can arise from muscle overactivity or underactivity/paralysis, resulting in a range of scapulothoracic abnormal motion (STAM). STAM can lead to various glenohumeral pathologies, including instability, impingement, or nerve compression. It is important to highlight the critical periscapular muscles involved in scapulohumeral rhythm (such as the upper, middle, and lower trapezius; rhomboid major and minor; serratus anterior; levator scapulae; and pectoralis minor). A discussion of the different etiologies of STAM should include examples of muscle dysfunction, such as overactivity of the pectoralis minor, underactivity or paralysis of the serratus anterior or trapezius muscles, and dyskinesis resulting from compensatory mechanisms in patients with recurrent glenohumeral instability due to Ehlers-Danlos syndrome. The evaluation and workup of STAM has shown that patients typically present with radiating shoulder pain, especially in the posterior aspect of the shoulder and scapula, and limitations in active shoulder overhead motion associated with glenohumeral pain, instability, or rotator cuff pathologies.",
          "authors": [
            "Eric R Wagner",
            "Zaamin B Hussain",
            "Anthony L Karzon"
          ],
          "year": "2024",
          "journal": "Instructional course lectures",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/38090927/"
        },
        {
          "pmid": "39055287",
          "title": "Dextrose Prolotherapy for the Treatment of Chronic Shoulder Pain in Patients With Joint Hypermobility: A Case Series.",
          "abstract": "Hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) are common causes of chronic musculoskeletal pain. Current practices rely on analgesics, physical therapy, bracing, and assistive devices. Dextrose prolotherapy (DPT) is a regenerative injection modality used to treat chronic painful musculoskeletal conditions through stimulation of tissue proliferation. The effectiveness of DPT for the treatment of chronic shoulder pain in patients with hEDS/HSD has not been established in the literature. Three patients with hEDS or HSD presented with refractory shoulder pain due to microinstability. Patients were treated with 20% DPT injected in the glenohumeral joint and surrounding structures as indicated. Outcomes assessed were pain and clinical improvement in joint stability at 2- to 7-week follow-up intervals. All patients reported subjective improvement in their shoulder pain and function. Disabilities of the Arm, Shoulder and Hand (DASH) scores after DPT decreased from initial assessment in all patients. Patients reported a cumulative improvement in pain and joint stability with each injection. Regenerative treatment with DPT may help restore structural integrity of affected joints and serve as an adjunctive therapy for the management of chronic shoulder pain due to microinstability in patients with hEDS/HSD.",
          "authors": [
            "Nathan Michalak",
            "Dylan Banks",
            "Luke Kane"
          ],
          "year": "2024",
          "journal": "Clinical medicine insights. Arthritis and musculoskeletal disorders",
          "doi": "10.1177/11795441241264821",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39055287/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "36061080",
          "title": "Increase in clivo-axial angle is associated with clinical improvement in children undergoing occipitocervical fusion for complex Chiari malformation: patient series.",
          "prevalence_mentions": [
            {
              "percentage": 80.0,
              "context": "were headache, neck/shoulder pain, and dysphagia; 80% of the cohort had improved clinical outcomes. cxa inc"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "stiffness",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "40626694",
          "title": "Genetic Diseases Mimicking Rheumatic Disorders: Insights From Southeastern Turkey.",
          "abstract": "A subset of genetic conditions, particularly skeletal dysplasias, comprises a heterogeneous group of inherited disorders characterized by abnormal bone development, joint stiffness, and short stature. Their musculoskeletal manifestations frequently mimic those of rheumatic diseases, especially Juvenile Idiopathic Arthritis (JIA), complicating accurate diagnosis. We conducted a comprehensive clinical, radiological, and molecular evaluation of 47 individuals (23 males, 24 females) from 22 distinct families who presented primarily with non-inflammatory musculoskeletal complaints. Genomic investigations included targeted next-generation sequencing panels, chromosomal microarray analysis, and multiplex ligation-dependent probe amplification. Pathogenic or likely pathogenic variants were identified in all cases, establishing the following diagnoses: Hereditary Multiple Exostoses (n‚Äâ=‚Äâ9), Camptodactyly-Arthropathy-Coxa Vara-Pericarditis syndrome (n‚Äâ=‚Äâ12), Progressive Pseudorheumatoid Dysplasia (n‚Äâ=‚Äâ7), Trichorhinophalangeal Syndrome types I/II (n‚Äâ=‚Äâ5), Spondyloenchondrodysplasia with Immune Dysregulation (n‚Äâ=‚Äâ6), Pseudoachondroplasia (n‚Äâ=‚Äâ3), Primary Hypertrophic Osteoarthropathy type 1 (n‚Äâ=‚Äâ1), Ehlers-Danlos Syndrome (n‚Äâ=‚Äâ2), Multicentric Osteolysis-Nodulosis-Arthropathy (n‚Äâ=‚Äâ1), and Mucopolysaccharidosis type VI (n‚Äâ=‚Äâ1). Certain genetic disorders may present with musculoskeletal manifestations that closely resemble those of rheumatic diseases. Therefore, a comprehensive evaluation for underlying genetic causes is essential in patients with non-inflammatory skeletal findings, as it improves diagnostic precision and guides appropriate management strategies. This study aims to investigate the clinical and molecular features of patients with non-inflammatory musculoskeletal involvement, with a particular focus on the phenotypic overlap between genetic disorders and rheumatic diseases. Furthermore, seven novel variants were identified, expanding the mutational spectrum associated with these rare conditions and contributing new insights to the existing literature.",
          "authors": [
            "Ak√ßahan Akalƒ±n",
            "Hatice Dilara Karaka≈ü",
            "Canan √áelebi"
          ],
          "year": "2025",
          "journal": "American journal of medical genetics. Part A",
          "doi": "10.1002/ajmg.a.64174",
          "url": "https://pubmed.ncbi.nlm.nih.gov/40626694/"
        },
        {
          "pmid": "34741592",
          "title": "Fascial thickness and stiffness in hypermobile Ehlers-Danlos syndrome.",
          "abstract": "There is a high prevalence of myofascial pain in people with hypermobile Ehlers-Danlos Syndrome (hEDS). The fascial origin of pain may correspond to changes in the extracellular matrix. The objective of this study was to investigate structural changes in fascia in hEDS. A series of 65 patients were examined prospectively-26 with hEDS, and 39 subjects with chronic neck, knee, or back pain without hEDS. The deep fascia of the sternocleidomastoid, iliotibial tract, and iliac fascia were examined with B-mode ultrasound and strain elastography, and the thicknesses were measured. Stiffness (strain index) was measured semi-quantitatively using elastography comparing fascia to muscle. Differences between groups were compared using one-way analysis of variance. hEDS subjects had a higher mean thickness in the deep fascia of the sternocleidomastoid compared with non-hEDS subjects. There was no significant difference in thickness of the iliac fascia and iliotibial tract between groups. Non-hEDS subjects with pain had a higher strain index (more softening of the fascia with relative stiffening of the muscle) compared with hEDS subjects and non-hEDS subjects without back or knee pain. In myofascial pain, softening of the fascia may occur from increase in extracellular matrix content and relative increase in stiffness of the muscle; this change is not as pronounced in hEDS.",
          "authors": [
            "Tina J Wang",
            "Antonio Stecco"
          ],
          "year": "2021",
          "journal": "American journal of medical genetics. Part C, Seminars in medical genetics",
          "doi": "10.1002/ajmg.c.31948",
          "url": "https://pubmed.ncbi.nlm.nih.gov/34741592/"
        },
        {
          "pmid": "32482891",
          "title": "Mechanisms of aortic carboxypeptidase-like protein secretion and identification of an intracellularly retained variant associated with Ehlers-Danlos syndrome.",
          "abstract": "Aortic carboxypeptidase-like protein (ACLP) is a collagen-binding extracellular matrix protein that has important roles in wound healing and fibrosis. ACLP contains thrombospondin repeats, a collagen-binding discoidin domain, and a catalytically inactive metallocarboxypeptidase domain. Recently, mutations in the ACLP-encoding gene, AE-binding protein 1 (",
          "authors": [
            "Neya Vishwanath",
            "William J Monis",
            "Gwendolyn A Hoffmann"
          ],
          "year": "2020",
          "journal": "The Journal of biological chemistry",
          "doi": "10.1074/jbc.RA120.013902",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32482891/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "25122555",
          "title": "Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients.",
          "prevalence_mentions": [
            {
              "percentage": 50.0,
              "context": "on stiffness and young's modulus were reduced to ‚àº50% of that in bjhs and ctrl groups (p<0.05). the nonhype"
            }
          ]
        },
        {
          "pmid": "32933483",
          "title": "Increased augmentation index in patients with Ehlers-Danlos syndrome.",
          "prevalence_mentions": [
            {
              "percentage": 34.0,
              "context": "patients were categorized in classical type eds (34%), hypermobile type eds (43%), vascular type eds ("
            },
            {
              "percentage": 43.0,
              "context": "n classical type eds (34%), hypermobile type eds (43%), vascular type eds (5%), or remained unassignabl"
            },
            {
              "percentage": 5.0,
              "context": "), hypermobile type eds (43%), vascular type eds (5%), or remained unassignable (18%) due to overlappi"
            },
            {
              "percentage": 18.0,
              "context": "vascular type eds (5%), or remained unassignable (18%) due to overlapping features. eds patients showed"
            },
            {
              "percentage": 22.8,
              "context": "ncreased aortic aix compared to healthy controls (22.8%‚Äâ¬±‚Äâ10.1 vs 14.8%‚Äâ¬±‚Äâ14.0, p‚Äâ<‚Äâ0.001). eds showed a p"
            },
            {
              "percentage": 14.8,
              "context": "aix compared to healthy controls (22.8%‚Äâ¬±‚Äâ10.1 vs 14.8%‚Äâ¬±‚Äâ14.0, p‚Äâ<‚Äâ0.001). eds showed a positive associat"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "nausea",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 6,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "37824142",
          "title": "Race and Ethnicity and Primary Language in Emergency Department Triage.",
          "abstract": "Emergency department (ED) triage substantially affects how long patients wait for care but triage scoring relies on few objective criteria. Prior studies suggest that Black and Hispanic patients receive unequal triage scores, paralleled by disparities in the depth of physician evaluations. To examine whether racial disparities in triage scores and physician evaluations are present across a multicenter network of academic and community hospitals and evaluate whether patients who do not speak English face similar disparities. This was a cross-sectional, multicenter study examining adults presenting between February 28, 2019, and January 1, 2023, across the Mass General Brigham Integrated Health Care System, encompassing 7 EDs: 2 urban academic hospitals and 5 community hospitals. Analysis included all patients presenting with 1 of 5 common chief symptoms. Emergency department nurse-led triage and physician evaluation. Average Triage Emergency Severity Index [ESI] score and average visit work relative value units [wRVUs] were compared across symptoms and between individual minority racial and ethnic groups and White patients. There were 249‚ÄØ829 visits (149‚ÄØ861 female [60%], American Indian or Alaska Native 0.2%, Asian 3.3%, Black 11.8%, Hispanic 18.8%, Native Hawaiian or Other Pacific Islander <0.1%, White 60.8%, and patients identifying as Other race or ethnicity 5.1%). Median age was 48 (IQR, 29-66) years. White patients had more acute ESI scores than Hispanic or Other patients across all symptoms (eg, chest pain: Hispanic, 2.68 [95% CI, 2.67-2.69]; White, 2.55 [95% CI, 2.55-2.56]; Other, 2.66 [95% CI, 2.64-2.68]; P‚Äâ<‚Äâ.001) and Black patients across most symptoms (nausea/vomiting: Black, 2.97 [95% CI, 2.96-2.99]; White: 2.90 [95% CI, 2.89-2.91]; P‚Äâ<‚Äâ.001). These differences were reversed for wRVUs (chest pain: Black, 4.32 [95% CI, 4.25-4.39]; Hispanic, 4.13 [95% CI, 4.08-4.18]; White 3.55 [95% CI, 3.52-3.58]; Other 3.96 [95% CI, 3.84-4.08]; P‚Äâ<‚Äâ.001). Similar patterns were seen for patients whose primary language was not English. In this cross-sectional study, patients who identified as Black, Hispanic, and Other race and ethnicity were assigned less acute ESI scores than their White peers despite having received more involved physician workups, suggesting some degree of mistriage. Clinical decision support systems might reduce these disparities but would require careful calibration to avoid replicating bias.",
          "authors": [
            "Joshua W Joseph",
            "Maura Kennedy",
            "Alden M Landry"
          ],
          "year": "2023",
          "journal": "JAMA network open",
          "doi": "10.1001/jamanetworkopen.2023.37557",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37824142/"
        },
        {
          "pmid": "37873998",
          "title": "Hyperemesis gravidarum and eating disorders before and after pregnancy: A register-based study.",
          "abstract": "Hyperemesis gravidarum (HG) is a severe form of excessive vomiting during pregnancy. The connection between psychiatric morbidity and HG has been debated, but only a few studies have focused on eating disorders (EDs). The objective of this study was to evaluate the association between HG and both pre-pregnancy and new post-pregnancy EDs. A register-based controlled study. HG diagnoses were retrieved from healthcare registers between 2005 and 2017. Women with HG in their first pregnancy resulting in delivery were chosen as cases (n‚Äâ=‚Äâ4265; the HG group) and women with no HG as controls (n‚Äâ=‚Äâ302,663; the non-HG group). The associations between EDs and HG were analyzed by binary logistic regression, adjusted with age, body mass index, smoking, socioeconomic status, and pre-pregnancy psychiatric diagnoses. In the HG group, 1.6% and in the non-HG group, 0.2% had a pre-pregnancy ED. Women with ED were more likely to have HG in their first pregnancy compared with women with no history of EDs (adjusted odds ratio [AOR] 9.4, 95% CI 6.52-13.66, p‚Äâ<‚Äâ.0001). Moreover, 0.4% of the women in the HG group and 0.1% of the women in the non-HG group had a new ED diagnosis after pregnancy, and thus the women in the HG group were more likely to have an ED diagnosis after pregnancy (AOR I 3.5, 95% CI 1.71-7.15, p‚Äâ<‚Äâ.001, AOR II 2.7, 95% CI 1.30-5.69, p‚Äâ=‚Äâ.008). We found a bidirectional association between ED and HG, suggesting a shared etiology or risk factors between these disorders. This finding emphasizes the importance of collaboration across various specialties when treating these patients. Our findings suggest a bidirectional association between HG and EDs before and after pregnancy. This finding provides essential information for healthcare professionals working with pregnant women. As both of these disorders are known to have far-reaching effects on the lives of both the mother and her offspring, our results help clinicians to target special attention and interventions to the patients suffering from these disorders.",
          "authors": [
            "Eeva Ter√§v√§-Utti",
            "Miina Nurmi",
            "Linda Laitinen"
          ],
          "year": "2024",
          "journal": "The International journal of eating disorders",
          "doi": "10.1002/eat.24082",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37873998/"
        },
        {
          "pmid": "39660107",
          "title": "Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.",
          "abstract": "Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD ( Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.",
          "authors": [
            "Ashley A Darakjian",
            "Mira Bhutani",
            "DeLisa Fairweather"
          ],
          "year": "2024",
          "journal": "Rheumatology advances in practice",
          "doi": "10.1093/rap/rkae134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39660107/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "37824142",
          "title": "Race and Ethnicity and Primary Language in Emergency Department Triage.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "ross most symptoms (nausea/vomiting: black, 2.97 [95% ci, 2.96-2.99]; white: 2.90 [95% ci, 2.89-2.91]; p"
            }
          ]
        },
        {
          "pmid": "37873998",
          "title": "Hyperemesis gravidarum and eating disorders before and after pregnancy: A register-based study.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "no history of eds (adjusted odds ratio [aor] 9.4, 95% ci 6.52-13.66, p‚Äâ<‚Äâ.0001). moreover, 0.4% of the w"
            }
          ]
        },
        {
          "pmid": "26376608",
          "title": "Ehlers Danlos syndrome and gastrointestinal manifestations: a 20-year experience at Mayo Clinic.",
          "prevalence_mentions": [
            {
              "percentage": 58.9,
              "context": "mean age 29.6 years). of the patients identified, 58.9% (43/73) had eds classic, 57.5% (271/471) eds hm, 4"
            },
            {
              "percentage": 57.5,
              "context": "tients identified, 58.9% (43/73) had eds classic, 57.5% (271/471) eds hm, 47.3% (27/57) eds vascular subty"
            },
            {
              "percentage": 47.3,
              "context": "(43/73) had eds classic, 57.5% (271/471) eds hm, 47.3% (27/57) eds vascular subtypes. in addition, 86 pat"
            },
            {
              "percentage": 56.1,
              "context": "ypes. commonest gi symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn"
            },
            {
              "percentage": 42.3,
              "context": "gi symptoms were: abdominal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and ir"
            },
            {
              "percentage": 38.6,
              "context": "minal pain (56.1%), nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome"
            },
            {
              "percentage": 37.6,
              "context": "nausea (42.3%), constipation (38.6%), heartburn (37.6%), and irritable bowel syndrome-like symptoms (27."
            },
            {
              "percentage": 27.5,
              "context": ".6%), and irritable bowel syndrome-like symptoms (27.5%). many gi symptoms were commoner in eds hm than t"
            },
            {
              "percentage": 37.8,
              "context": "in eds hm than the other subtypes together. among 37.8% of the 378 patients who underwent esophagogastroduode"
            },
            {
              "percentage": 38.0,
              "context": "els in eds vascular type. proton pump inhibitors (38%) and drugs for constipation (23%) were the most c"
            },
            {
              "percentage": 2.9,
              "context": "used medications. a minority underwent colectomy (2.9%) or small bowel surgery (4%). eds hm and other su"
            },
            {
              "percentage": 4.0,
              "context": "nderwent colectomy (2.9%) or small bowel surgery (4%). eds hm and other subtypes should be considered"
            }
          ]
        },
        {
          "pmid": "34264326",
          "title": "High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.",
          "prevalence_mentions": [
            {
              "percentage": 2.0,
              "context": "ine were identified. nausea or vomiting was rare (2%-6% of cases). the median (interquartile range) le"
            },
            {
              "percentage": 6.0,
              "context": "were identified. nausea or vomiting was rare (2%-6% of cases). the median (interquartile range) length of"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "depression",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "39660107",
          "title": "Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.",
          "abstract": "Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD ( Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.",
          "authors": [
            "Ashley A Darakjian",
            "Mira Bhutani",
            "DeLisa Fairweather"
          ],
          "year": "2024",
          "journal": "Rheumatology advances in practice",
          "doi": "10.1093/rap/rkae134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39660107/"
        },
        {
          "pmid": "28967365",
          "title": "Hypermobility, the Ehlers-Danlos syndromes and chronic pain.",
          "abstract": "Chronic widespread pain is a common complaint among individuals affected by generalised joint hypermobility. In the absence of other conditions that cause chronic pain, these individuals are usually diagnosed with joint hypermobility syndrome (JHS). JHS is a multifactorial trait with a strong genetic basis, but no specific genetic markers. Clinical overlap of JHS is seen with heritable connective tissue disorders, particularly with the Ehlers-Danlos syndrome, hypermobile type (hEDS). The Ehlers-Danlos syndromes (EDS) comprise a heterogeneous group of rare monogenic conditions that are characterised by joint hypermobility, skin and vascular fragility and generalised connective tissue friability, and are caused by genetic defects in an array of extracellular matrix genes. The genetic basis of hEDS remains however unknown, in contrast to other well-described EDS subtypes. In view of the considerable clinical overlap with JHS, many consider it and hEDS to be a single clinical entity. Clinical experience and a limited number of clinical studies show that chronic pain also is common in EDS patients, especially in hEDS. The specific underlying causes and mechanisms of pain in JHS and EDS remain poorly understood. Factors likely contributing to the generation and chronicity of pain include nociceptive pain, directly based on structural changes in affected joints, muscle and connective tissue; neuropathic pain; impaired proprioception and muscle weakness; and central sensitisation. These mechanisms are not mutually exclusive, and likely more than one mechanism may be present. Furthermore, anxiety, depression, and other variables may influence the phenotype. Chronic pain in JHS and EDS patients often is inadequately controlled by traditional analgesics and physical therapy. In view of the high prevalence of these underrecognised conditions, future studies addressing the nature and mediators of chronic pain are needed in order to potentially identify novel targets for therapeutic intervention and optimise treatment.",
          "authors": [
            "Delfien Syx",
            "Inge De Wandele",
            "Lies Rombaut"
          ],
          "year": "2017",
          "journal": "Clinical and experimental rheumatology",
          "doi": null,
          "url": "https://pubmed.ncbi.nlm.nih.gov/28967365/"
        },
        {
          "pmid": "32679923",
          "title": "Eating Disorders in Pregnant and Breastfeeding Women: A Systematic Review.",
          "abstract": "",
          "authors": [
            "Mar√≠a Mart√≠nez-Olcina",
            "Jacobo A Rubio-Arias",
            "Cristina Reche-Garc√≠a"
          ],
          "year": "2020",
          "journal": "Medicina (Kaunas, Lithuania)",
          "doi": "10.3390/medicina56070352",
          "url": "https://pubmed.ncbi.nlm.nih.gov/32679923/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "39217528",
          "title": "Associations Between Gender Dysphoria, Eating Disorders, and Mental Health Diagnoses Among Adolescents.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "also having a diagnosis of anxiety (aor¬†= 24.01, 95% ci: 14.85-38.83), depression (aor¬†= 48.41, 95% ci:"
            },
            {
              "percentage": 95.0,
              "context": "1, 95% ci: 14.85-38.83), depression (aor¬†= 48.41, 95% ci: 30.38-77.12), suicidality (aor¬†= 26.15, 95% ci"
            }
          ]
        },
        {
          "pmid": "29497845",
          "title": "Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.",
          "prevalence_mentions": [
            {
              "percentage": 12.8,
              "context": "in the high-anxious group (80.5 vs 56.4; 26.8 vs 12.8%, respectively). high-anxious heds patients also s"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "exhaustion",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "37266186",
          "title": "Burnout among Japanese emergency medicine physicians: A multicentric questionnaire study.",
          "abstract": "Burnout negatively affects the wellness and performance of emergency physicians (EPs). This study aimed to clarify the actual prevalence of burnout and its associated factors among Japanese EPs. We conducted a cross-sectional questionnaire study of selected 27 Japanese emergency departments (EDs). We examined the Maslach Burnout Inventory-Human Services Survey score and its associations with ED-level- and EP-level factors in a multivariable analysis. A total of 267 EPs (81.9%) completed survey. Of these, 43 EPs (16.1%) scored severe emotional exhaustion (EE), 53 (19.8%) scored severe depersonalization (DP), and 179 (67.0%) scored severe personal accomplishment (PA), and 24 (8.9%) scored severely in all three domains. In our multivariable analysis, emergency medical service centers were associated with severe PA scores (odds ratio [OR], 10.56; 95% confidence interval [CI], 1.78-62.66;  Our results suggest that 8.9% of Japanese EPs are in higher degrees of burnout. In particular, Japanese EPs scored more severely on PA. To avoid burnout in Japanese EPs, it is important to improve the working environment by ensuring more than 6‚Äâh of sleep, providing more support for young EPs, and taking effective action to combat low EP self-esteem.",
          "authors": [
            "Miki Morikawa",
            "Takahiro Uechi",
            "Nao Hanaki"
          ],
          "year": "2023",
          "journal": "Acute medicine & surgery",
          "doi": "10.1002/ams2.848",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37266186/"
        },
        {
          "pmid": "33505543",
          "title": "Trends and challenges of emergency and acute care in Chinese mainland: 2005-2017.",
          "abstract": "Emergency medical service system (EMSS) is essential in providing acute care services for health conditions. However, trends of emergency and acute care in China haven't been studied systematically. Relevant literature was carefully reviewed, including original and review articles, letters, government reports, yearbooks, both in Chinese and in English. Data on the number of emergency visits, physicians and beds in emergency departments (EDs), and the workforce of pre-hospital emergency care were summarized and analyzed from  Over the past decade, the number of ED visits tripled from 51.9 million to 166.5 million; and utilization of pre-hospital emergency care increased from 3.2 million to 6.8 million. In response to rapid increases in demand, the number of licensed emergency physicians raised from 20,058 to 59,409; the beds' number increased from 10,783 to 42,367. For pre-hospital emergency care, the volume of health workforce increased from 3,687 to 8,671, with a 109% increase in the number of physicians from 1,774 to 3,712. However, overcrowding, the long length of stay in EDs, poor work environment, and work exhaustion were still the critical challenges faced by China's EMSS. The number of emergency visits has grown with continual capability enhancement during the past decade. However, overcrowding, the long length of stay in EDs, poor work environment, and work exhaustion still need to be solved by China's EMSS. These findings and comparison with the USA could offer experiences and lessons to EMSS development worldwide, especially for developing countries.",
          "authors": [
            "Chang Pan",
            "Jiao-Jiao Pang",
            "Kai Cheng"
          ],
          "year": "2021",
          "journal": "World journal of emergency medicine",
          "doi": "10.5847/wjem.j.1920-8642.2021.01.001",
          "url": "https://pubmed.ncbi.nlm.nih.gov/33505543/"
        },
        {
          "pmid": "37759190",
          "title": "Impact of the COVID-19 pandemic crisis on turnover intention among nurses in emergency departments in Thailand: a cross sectional study.",
          "abstract": "During the COVID-19 pandemic in Thailand, a large volume of COVID-19 patients were referred to hospital emergency departments (EDs). This increased job demand and job strain among ED nurses, resulting in a high risk of intention to leave their organization. To investigate turnover intention during the COVID-19 pandemic among ED nurses and examine the effect of organizational resources, maladaptive regulation, and job burnout on nurses' turnover intention. This cross-sectional study investigated 322 ED nurses. We divided participants into two groups: dark-red zone areas (pandemic crisis areas) and non-red zone areas (non-pandemic crisis areas). Descriptive statistics, Pearson's correlation analysis, and multiple linear regression (forward stepwise method) were used to analyze factors that predicted turnover intention. Most participants were female and the mean age was 34.54 years. During COVID-19 pandemic crisis, 72.8% of ED nurses in dark-red zone areas desired to leave their organization. The factors of motivation, exhaustion, and cognitive impairment positively influenced turnover intention among ED nurses in dark-red zone areas. Low availability of organizational resources was associated with an increase in the turnover intention rate. Maladaptive regulation, exhaustion, and cognitive impairment positively influenced turnover intention among ED nurses in non-red zone areas. Exhaustion and cognitive impairment stand as significant facets of burnout linked to the intention of turnover among ED nurses. To address this, we recommend fostering secure workplace settings and implementing interventions that alleviate job demands and strains for ED nurses, potentially reducing turnover intentions.",
          "authors": [
            "Songwut Sungbun",
            "Siripan Naknoi",
            "Panjasilpa Somboon"
          ],
          "year": "2023",
          "journal": "BMC nursing",
          "doi": "10.1186/s12912-023-01495-3",
          "url": "https://pubmed.ncbi.nlm.nih.gov/37759190/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "37266186",
          "title": "Burnout among Japanese emergency medicine physicians: A multicentric questionnaire study.",
          "prevalence_mentions": [
            {
              "percentage": 16.1,
              "context": "7 eps (81.9%) completed survey. of these, 43 eps (16.1%) scored severe emotional exhaustion (ee), 53 (19."
            },
            {
              "percentage": 19.8,
              "context": ".1%) scored severe emotional exhaustion (ee), 53 (19.8%) scored severe depersonalization (dp), and 179 (6"
            }
          ]
        },
        {
          "pmid": "33892131",
          "title": "Excessive daytime sleepiness is associated with an increased frequency of falls and sarcopenia.",
          "prevalence_mentions": [
            {
              "percentage": 70.4,
              "context": "75 outpatients (mean age 78.7¬†¬±¬†7.5¬†years, female:70.4%), the prevalence of eds was 19.8%. in the multiva"
            },
            {
              "percentage": 19.8,
              "context": "5¬†years, female:70.4%), the prevalence of eds was 19.8%. in the multivariable model adjusted for age, sex"
            },
            {
              "percentage": 95.0,
              "context": "94, 95% ci: 1.42-2.65) and sarcopenia (or¬†=¬†2.41, 95% ci: 1.41-4.12). eds was not significantly associat"
            }
          ]
        }
      ]
    }
  },
  {
    "symptom": "hopelessness",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "31765024",
          "title": "Meaning in life moderates hopelessness, suicide ideation, and borderline psychopathology in participants with eating disorders: A longitudinal study.",
          "abstract": "Participants with eating disorders (EDs) experience identity problems, hopelessness, and suicide ideation. Research has confirmed the link between the experience of low meaning in life (MIL) and psychopathology. However, there is a lack of research focusing on MIL in ED. The objectives of this study are as follows: (a) to analyze whether MIL at baseline moderates the association between ED psychopathology at baseline and borderline symptoms, hopelessness, and suicide ideation at follow-up and (b) to analyze whether MIL moderates the association between suicide ideation, hopelessness, and borderline symptoms at baseline and at the 7-month follow-up. The sample was composed of 300 participants with ED at baseline and 122 at the 7-month follow-up. The participants filled out the Purpose in Life, Eating Attitude Test, Borderline Symptoms List, Hopelessness Scale, and Suicide Ideation Scale. (a) MIL at baseline moderated the association between ED psychopathology at baseline and borderline symptoms, hopelessness, and suicide ideation at the follow-up; (b) MIL moderated the association between suicide ideation, hopelessness, and borderline symptoms at baseline and at the 7-month follow-up. MIL could be a relevant variable in the ED psychopathology.",
          "authors": [
            "Jos√© H Marco",
            "Montserrat Ca√±abate",
            "Gin√©s Llorca"
          ],
          "year": "2020",
          "journal": "Clinical psychology & psychotherapy",
          "doi": "10.1002/cpp.2414",
          "url": "https://pubmed.ncbi.nlm.nih.gov/31765024/"
        },
        {
          "pmid": "38810783",
          "title": "Distinct personality profiles associated with disease risk and diagnostic status in eating disorders.",
          "abstract": "Personality traits have been associated with eating disorders (EDs) and comorbidities. However, it is unclear which personality profiles are premorbid risk rather than diagnostic markers. We explored associations between personality and ED-related mental health symptoms using canonical correlation analyses. We investigated personality risk profiles in a longitudinal sample, associating personality at age 14 with onset of mental health symptoms at ages 16 or 19. Diagnostic markers were identified in a sample of young adults with anorexia nervosa (AN, n¬†=¬†58) or bulimia nervosa (BN, n¬†=¬†63) and healthy controls (n¬†=¬†47). Two significant premorbid risk profiles were identified, successively explaining 7.93¬†% and 5.60¬†% of shared variance (R The samples were not ethnically diverse. The clinical cohort included only females. There was non-random attrition in the longitudinal sample. The results suggest neuroticism and impulsivity as risk and diagnostic markers for EDs, with neuroticism and hopelessness as shared diagnostic markers. They may inform the design of more personalised prevention and intervention strategies.",
          "authors": [
            "Zuo Zhang",
            "Lauren Robinson",
            "Iain Campbell"
          ],
          "year": "2024",
          "journal": "Journal of affective disorders",
          "doi": "10.1016/j.jad.2024.05.132",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38810783/"
        },
        {
          "pmid": "35334350",
          "title": "Demoralization in suicide: A systematic review.",
          "abstract": "In psychiatric literature, few original studies exist on the topic of demoralization in suicide. In this review, we aim to identify original studies on suicidal ideation (SI)/suicidal behavior (SB) and demoralization in populations of community-dwellers and patients with somatic or psychiatric disorders. We employed a systematic approach that followed PRISMA guidelines, searching through four major electronic databases (PubMed/MEDLINE, Scopus, Science Direct, and PsychINFO) for relevant titles/abstracts published from January 1980-June 2021. We included original studies that explicitly mentioned the investigation of a potential association between SI/SB and demoralization. A total of 18 studies met our inclusion criteria. Their synthesis revealed that demoralization can be associated with SI/SB in a wide range of populations (community dwellers, patients with somatic or psychiatric disorders) and lead to significantly higher suicide risk (odds ratios of >6 were encountered in community dwellers experiencing financial hardship or isolation). Moreover, demoralization alone (about half the patients who were demoralized did not meet the criteria for an affective disorder nor were they clinically depressed) or together with depression has been identified as a major risk factor for SI/SB. Regarding the crucial issue of progression from SI to SA, in the context of the \"ideation-to-action\" frame, some authors found that the interaction of demoralization and over-arousal could be a useful predictor for this progression, while others found that depression alone was sufficient to differentiate attempters from non-attempters or the interaction with shutdown (helplessness and low positive emotions). These results emphasize the possibility to identify demoralization as an independent risk factor for suicide. In patients with psychiatric disorders, the association between demoralization and SI/SB may be transnosographic. Overall, from the clinical implications perspective, our findings highlight that: i. Assessment of demoralization may contribute to a more comprehensive suicide risk detection. This appears particularly relevant in Emergency Departments (EDs) where heterogeneous population typologies are usually admitted and a clinical diagnosis of depression is often difficult to be defined. ii. Additionally, since meaninglessness is considered one of the demoralization subcomponents, meaning-centered psychotherapeutic approaches prove to be indicated and they can be initiated already at the EDs upon first contact with the patient. Further studies are necessary to confirm these findings.",
          "authors": [
            "Alessandra Costanza",
            "Chytas Vasileios",
            "Julia Ambrosetti"
          ],
          "year": "2022",
          "journal": "Journal of psychosomatic research",
          "doi": "10.1016/j.jpsychores.2022.110788",
          "url": "https://pubmed.ncbi.nlm.nih.gov/35334350/"
        }
      ],
      "prevalence_data": []
    }
  },
  {
    "symptom": "headache",
    "evidence_tier": 2,
    "tier_label": "‚úÖ Research-Backed",
    "surprise_score": 0.008,
    "surprise_label": "‚úì Expected",
    "reddit_data": {
      "mention_count": 5,
      "frequency": 0.01556420233463035,
      "post_ids": []
    },
    "pubmed_data": {
      "paper_count": 10,
      "papers": [
        {
          "pmid": "39660107",
          "title": "Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.",
          "abstract": "Patients with hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) experience a wide array of symptoms and system disorders. This study aimed to identify whether differences occurred in 115 self-reported symptoms and comorbidities in patients diagnosed with hEDS or HSD. In this study we analysed self-reported data from an EDS Clinic intake questionnaire in patients diagnosed with hEDS, HSD or no hypermobile conditions. From 1 November 2019 to 7 March 2024, the EDS Clinic saw 2088 patients. Using the 2017 diagnostic criteria, 66.5% were diagnosed with HSD ( Although we found an overlap in some symptoms and comorbidities self-reported by hEDS/HSD patients, such as allergy/atopy, headache/migraine and gastrointestinal symptoms, our findings suggest key differences exist between the two diagnoses, suggesting that hEDS and HSD may be distinct conditions.",
          "authors": [
            "Ashley A Darakjian",
            "Mira Bhutani",
            "DeLisa Fairweather"
          ],
          "year": "2024",
          "journal": "Rheumatology advances in practice",
          "doi": "10.1093/rap/rkae134",
          "url": "https://pubmed.ncbi.nlm.nih.gov/39660107/"
        },
        {
          "pmid": "38003876",
          "title": "Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.",
          "abstract": "Mast cell activation syndrome (MCAS) is an immune disease with an estimated prevalence of 17%. Mast cell chemical mediators lead to heterogeneous multisystemic inflammatory and allergic manifestations. This syndrome is associated with various neurologic and psychiatric disorders, including headache, dysautonomia, depression, generalized anxiety disorder, and many others. Although MCAS is common, it is rarely recognized, and thus, patients can suffer for decades. The syndrome is caused by aberrant mast cell reactivity due to the mutation of the controller gene. A case series is presented herein including eight patients with significant neuropsychiatric disorders that were often refractory to standard medical therapeutics. Five patients had depression, five had generalized anxiety disorder, and four had panic disorder. Other psychiatric disorders included attention-deficit hyperactivity disorder, obsessive compulsive disorder, phobias, and bipolar disorder. All eight patients were subsequently diagnosed with mast cell activation syndrome; six had comorbid autonomic disorders, the most common being postural orthostatic tachycardia syndrome; and four had hypermobile Ehlers-Danlos syndrome. All patients experienced significant improvements regarding neuropsychiatric and multisystemic symptoms after mast-cell-directed therapy. In neuropsychiatric patients who have systemic symptoms and syndromes, it is important to consider the presence of an underlying or comorbid MCAS.",
          "authors": [
            "Leonard B Weinstock",
            "Renee M Nelson",
            "Svetlana Blitshteyn"
          ],
          "year": "2023",
          "journal": "Journal of personalized medicine",
          "doi": "10.3390/jpm13111562",
          "url": "https://pubmed.ncbi.nlm.nih.gov/38003876/"
        },
        {
          "pmid": "25196367",
          "title": "Joint hypermobility and headache.",
          "abstract": null,
          "authors": [
            "Brad T Tinkle"
          ],
          "year": "2014",
          "journal": "Headache",
          "doi": "10.1111/head.12416",
          "url": "https://pubmed.ncbi.nlm.nih.gov/25196367/"
        }
      ],
      "prevalence_data": [
        {
          "pmid": "36082197",
          "title": "Cervical Artery Dissections: Etiopathogenesis and Management.",
          "prevalence_mentions": [
            {
              "percentage": 95.0,
              "context": "ns related to cead are headache and neck pain (65-95%), tia/ischemic stroke (>50%), and partial horner'"
            }
          ]
        },
        {
          "pmid": "39266054",
          "title": "Subarachnoid haemorrhage in the emergency department (SHED): a prospective, observational, multicentre cohort study.",
          "prevalence_mentions": [
            {
              "percentage": 64.1,
              "context": "re enrolled from 88 eds (mean age 45.8 (sd 16.6), 64.1% female). 3268 patients (89.2%) underwent ct-brain"
            },
            {
              "percentage": 6.5,
              "context": "were 237 cases of confirmed sah, a prevalence of 6.5%. ct within 6‚Äâhours of headache onset (n=772) had"
            },
            {
              "percentage": 97.0,
              "context": "rs of headache onset (n=772) had a sensitivity of 97% (95% ci 92.5% to 99.2%) for the diagnosis of sah a"
            },
            {
              "percentage": 95.0,
              "context": "headache onset (n=772) had a sensitivity of 97% (95% ci 92.5% to 99.2%) for the diagnosis of sah and a"
            },
            {
              "percentage": 95.0,
              "context": "to 1.3%). the negative likelihood ratio was 0.03 (95% ci 0.01 to 0.08). ct within 24 hours of headache o"
            },
            {
              "percentage": 94.6,
              "context": "s of headache onset (n=2008) had a sensitivity of 94.6% (95% ci 91.0% to 97.0%). post-test probability for"
            }
          ]
        }
      ]
    }
  }
]